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INTRODUCTION 
Since the introduction of cervical cytological sampling for the diagnosis of cancer 
and premalignant lesions, the surface of the uterine cervix has become one of the 
most extensively studied areas (56,75). As a consequence of these efforts it is now 
generally accepted that invasive squamous cell carcinoma of the uterine cervix 
develops through a continuum of intraepithelial changes representing stages of 
malignant transformation of the cervical mucosa. By recognizing intraepithelial 
neoplastic changes, a potentially malignant transformation can be identified in an 
early phase before signs or symptoms have occurred, although many epithelial 
abnormalities may mimic true progressive changes. Therefore during the last 
decades many studies have concentrated on the morphological or functional 
identification of true progressive intraepithelial abnormalities. 
The uterine cervix is located in such a way, that cytological, histological and 
colposcopical examination is relatively simple. The surface of the uterine cervix 
is covered by several layers of squamous cells on the ectocervix and by a single 
layer of columnar epithelium in the endocervical canal. These two types of 
epithelium meet at the so called squamocolumnar junction. During adolescence 
this junction is turned outward and as a consequence a relatively large area of 
columnar epithelium, the transformation zone, is exposed to the vagina. In 
response to the acidity of the vaginal environment the columnar epithelium may 
undergo squamous metaplasia, passing through the phases of reserve cell hyperpla-
sia and immature squamous metaplasia. In this area dedifferentiation of the 
epithelium may occur leading to the development of invasive squamous cell 
carcinoma. These epithelial changes have rather arbitrarily been subdivided into 
slight dysplasia (= Cervical Intraepithelial Neoplasia grade 1 = CINI), moder-
ate dysplasia (CIN II) and severe dysplasia and Carcinoma in Situ (CIN III). The 
histopathological subdivision is paralleled by an increasing atypia, irregular arrange-
ment of the cells and increased mitotic activity. 
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NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA 
Despite the large amount of cytological and epidemiological data that has become 
available, the cellular biology of premalignant cervical lesions has not yet been 
solved. There are considerable differences in the results of follow-up studies, 
depending on issues like different interpretation of cytological and histological 
features and different statistical approaches of epidemiological data (10,20,26,35, 
38,52,58,59,64,70,76,78,82,84,95). A study that often has been referred to is the 
study of Richart and Barron, who performed a follow-up study of 557 women, 
with abnormal smears, the most severe lesion of these being moderate dysplasia 
(CIN II) (84). Patients were followed by cytological and colposcopical exam­
inations without interference of punch biopsies or other treatment. The average 
follow-up period was 36 months. Using a statistical model they calculated that in 
a 10 year period moderate dysplasia would progress to a more severe lesion in 
about 90 % of cases. Patients were admitted only after three (successive) abnor­
mal smears. 
In table 1 an overview of some of the literature on the natural history of cervical 
intraepithelial neoplasia is presented in more detail. 
Table 1: Overview of some of the literature on the natural history of cervical intraepithelial neoplasia. 
Nasiell 
Hall 
Richart 
Fox 
Koss 
Villa S. 
Kottmeiei 
Petersen 
Kinlen 
Green 
Mcindoe 
N of 
Pat. 
411 
85 
557 
278 
33 
26 
67 
63 
• 31 
127 
52 
576 
131 
Select.* 
Cri ter. 
С 
B+C 
C/3xdys. 
С 
С 
В+С 
В+С 
В+С 
В+С 
В+С 
С 
В+С 
В+С 
Initial 
Diagnosis 
CIN2 
CIN2 
dysplasia 
CINI+2 
CIN3 
CINI+2 
CIS 
dysplasia 
CIS 
atypia 
Pap4-5 
CIS 
CIS 
Regr. 
50% 
33% 
6% 
31% 
R+P 
39% 
25% 
48% 
-
-
37% 
8% 
Persist. 
15% 
49% 
-
9% 
100% 
15% 
61% 
16% 
-
-
38% 
69% 
Progr. 
35% 
18% 
94% 
59% 
-
42% 
-
16% 
-
-
-
-
Progr. 
(CIN3) 
0.3% 
-
-
1% 
-
4% 
Follow-up 
(INV)period 
50-78 mon. 
1-14 yrs 
36 months 
15-40 mon. 
1/2-7 yrs 
6%(13%) 
21% 
71% 
27% 
25% 
0.17% 
22% 
0-8 yrs 
>12 yrs 
3-16 yrs 
>2 yrs 
1-12 yrs 
1-28 yrs 
* B+C: Cytologic follow up after initial histological diagnosis, both representing CIN lesions. 
C: Cytologically followed, no histological examination prior to treatment. 
Mild and moderate dysplasia are referred to as CIN I and II, respectively. 
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Many reports of follow-up studies dealt with CIN I and II lesions. Data on the 
follow-up of CIN III lesions are less frequent. Some studies were based on 
cytological follow-up alone, others on cytological examination after initial biopsies 
or conisations. Nasiell et al followed cytologically 894 women with moderate 
dysplasia (CIN II) (70). Patients were entered into the study after one smear 
indicating moderate dysplasia. Biopsies were performed in 483 (54 %) women. 
Results of 411 cases without biopsy were: regression in 50 %, persistence in 15 
% and progression in 35 %. Invasive carcinoma occurred in three patients (0.3 
%). The average follow-up period was 78 months for cases that showed regression, 
50 months for cases that showed persistence and 51 months for cases that showed 
progression. In a study of Hall and Walton 85 cases of moderate dysplasia were 
followed by cytological and histological examination from one to 14 years (38). 
The regression rate was 33%, persistence 49% and progression to carcinoma in 
situ in 18%. No invasive carcinoma was seen. In a study of 278 patients with 
initial cytological diagnosis of mild or moderate dysplasia (CIN I and II), Fox 
found percentages for regression and persistence of 31 and 8.9 respectively (27). 
The reported progression to severe dysplasia and carcinoma in situ (CIN III) was 
59 % and to invasive squamous cell carcinoma 1.1 %. Most of these lesions 
were undisturbed by tissue study. In his study, Fox also reported follow-up results 
of 33 cases of severe dysplasia and carcinoma in situ, that were diagnosed and 
followed by cytological examination alone. In this series no invasive carcinoma 
occurred (27). The follow-up period was 15 to 40 months. In an early paper, Koss 
reported a group of 26 women with "borderline" lesions of the cervix, comprising 
mild and moderate dysplasia (CIN I and II) (58). Regression was seen in 39 %, 
persistence in 15 %, progression to CIN III in 46 % and to invasive carcinoma 
in 4 %. Initial diagnoses were established by biopsy. Follow-up was by cytological 
examination only. The follow-up period was seven months to 10 years. Koss et 
al further reported follow-up data of a group of 67 women with carcinoma in situ 
of the cervix, initially diagnosed by biopsy. Four cases progressed to invasive 
cancer (6%) and five cases developed questionable invasion (7%) (58). Regression 
was present in 25 % and persistence in 61 %. Kottmeier reported in 1961 that 
22 (71%) patients of a group of 31 patients with CIS, who had been followed for 
at least 12 years, had developed invasive carcinoma (59). Petersen reported follow-
up data of a group of 127 patients with epithelial atypia, who developed invasive 
cancer in 27% of cases (78). Kinlen and Spriggs presented follow-up data of a 
group of 131 women with a cytological diagnosis of unsuspected positive smear 
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(Papanicolaou Class IV or V) who had been lost to follow-up for at least two 
years (52). They traced 52 women, with positive cervical smears at least two years 
previously but who were not treated and had had no biopsies. Thirteen (25 %) 
of these women had developed invasive carcinoma. Nineteen (37%) had no 
apparent abnormalities when reexamined. In 20 patients (38%) at follow up CIS 
or dysplasia was diagnosed. Further studies were carried out in the National 
Women's Hospital, Auckland, New Zealand by Green and others (35,64). Initially 
Green and Donovan found a progression rate to invasive cancer in patients with 
cervical carcinoma in situ, diagnosed by cone biopsy, of 0.17%. One of their 
statements was that either the length of the preinvasive phase of cervical squa-
mous cell carcinoma is much longer than 20 years or very few in situ cancer ever 
become invasive (35). Mcindoe et al from the same hospital, presented in 1984 
an overview of follow-up data of 948 patients with carcinoma in situ, initially 
diagnosed by biopsy or conization, followed from five to 28 years (64). One 
subgroup of 131 patients continued to produce abnormal cytology consistent with 
cervical extra epithelial neoplasia of which 29 (22%) developed invasive carcinoma 
of the cervix or vaginal vault. 
All these studies have been criticized in one way or another. Regarding technical 
aspects, it has been argued that if the initial diagnosis was made at histological 
examination, the lesion itself may have been removed or altered in such a way 
that regression of the lesion was promoted (58,84). On the other hand cytological 
examination alone has been considered to be inaccurate at diagnosing the earliest 
stages of cervical invasion. Concerning ethical aspect of these studies, it has 
become clear that once a risk of progression from carcinoma in situ to invasive 
cancer is accepted, it is ethically not acceptable not to treat patients at the 
carcinoma in situ stage (26,77). 
These studies have shown that CIN lesions indeed may progress into invasive 
cancer. Furthermore it has become clear that CIN I as well as CIN III lesions 
may progress to invasive cancer (58,84). A significant part of the CIN lesions 
when left untreated will however not have a progressive course. The precise 
frequency of progression of CIN into invasive cancer still remains unknown. Koss 
recently stated in an overview article that the ratio of precancerous lesions of the 
uterine cervix to invasive cancer is probably of the order of 10 to 1, possibly even 
higher, and that as such, at most one in ten precancerous lesions is likely to 
progress to invasive cancer, when left untreated (56). 
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But whatever the precise percentage of progression or non-progression of CIN 
may be, light microscopically CIN I-III lesions can not be subdivided in progressi-
ve, persistent or regressive subtypes. Therefore most patients with CIN lesions are 
actually being treated as essentially premalignant, potentially progressive lesions. 
A technique that could distinguish between really potentially progressive and 
potentially regressive or reactive lesions would be very welcome for everyone 
involved. 
In the Netherlands about 1200 new cases of cervical invasive squamous cell 
carcinoma occur per year (33,36). The prevalence of CIN I, II, and III lesions 
in the Netherlands as detected by cytological screening is not known precisely. 
It has been estimated that per year, in about 1% of women, in the age category 
35 to 55 years, CIN I, II or III lesions may be detected (34). On a total populati-
on of 2,000,000 Dutch women in this age group, this signifies 20,000 cases of 
cytologically detected CIN lesions per year. Recently it was proposed by the Dutch 
Scientific Societies of Pathology and Obstetrics and Gynecology, that all cases of 
CIN II or III (and CIN I after one repeated positive smear), should be colposco-
pically evaluated (96). This would mean a very high number of colposcopical 
examinations and as a likely consequence a large increase in the number of 
histological examinations, conisations, laser evaporizations, cryocoagulations, 
diathermic ablatios and hysterectomies a year. These figures indicate the importan-
ce of the development of effective progression markers in cervical cytology. If the 
statement of Koss is right that only 10% or less of all CIN lesions will progress 
into invasive carcinoma, such progression markers could give a large saving on 
the emotional and financial costs. The subject of this thesis is the assessment of 
the possible role of DNA-cytometry for the detection of progressive and non-
progressive cervical intraepithelial lesions. The possible role of human papilloma 
virus will be discussed briefly. 
HUMAN PAPILLOMA VIRUS 
Epidemiologic studies have shown that cervical carcinoma behaves as a venereally-
transmitted infection in which one or more agents are transmitted to the women 
by male patients (51,54,86). High risk factors for cervical carcinoma are low age 
at the onset of sexual activity and having had multiple sexual partners or sexual 
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promiscuity. Coppleson and Reíd suggested that spermatozoa may trigger neoplas-
tic events in the cervical epithelium (22). Transmissible agents that have been 
studied are treponema pallidum, diplococcus gonorrhoea, trichomonas vaginalis, 
herpes simplex virus type 2 (HSV 2) and human papilloma virus (HPV). 
The human papilloma virus is closely related to the SV40 virus and Shope 
papillomavirus, which can produce malignant tumors in animals. It is thought that 
HPV has a potential as an oncogenic virus in the human. No tissue culture system 
exists however that could support the growth and maturation of HPV in vitro. 
The relation between HPV infection and CIN and cancer has been based purely 
on observations made in tissues in vivo (1,25). The presence of HPV may be 
suggested in cervical smears by koilocytes, squamous cells with enlarged hyper-
chromatic nuclei and large clear perinuclear zones which are sharply demarcated 
against the peripheral cytoplasm (55,65,81). Other features that can be seen m 
epithelial lesions related to HPV, are multmucleation and individual keratmization, 
parakeratosis, epithelial pearl formation, acanthosis, frequent mitotic figures and 
prominent rete pigs (53,67). These histopathological features, that have been 
described as flat condyloma or subclinical papillomavirus infection (SPI) may be 
seen intermingled with changes present in CIN lesions or adjacent to CIN lesions 
(66,83). The virus can be demonstrated in biopsies and cervical smears by elec-
tronmicroscopical detection of HPV specific spherical crystalline particles with a 
diameter of 52 to 55 nm (43,61) or by immunochemical techniques, demonstrating 
viral capsid proteins mostly in the intermediate and superficial epithelial layers 
(48,60,99). Using molecular hybridization techniques such as Southern blotting, blot 
hybridization, and in situ hybridization, HPV DNA has been demonstrated in 
cervical intraepithelial neoplasia and invasive carcinoma. Approximately 50 types 
ot HPV have been identified to date (18,25,30,63,72,79,101,102). Reviewing the 
literature, Zur Hausen concluded that HPV type 16 is found in approximately 
50% of all cervical, penile and vulvar cancers, and HPV 18 in close to 20% ot 
these lesions (102). It has been suggested that HPV may play a role as a promo-
tor. Neoplastic transformation might be determined by specific HPV types but, 
it requires an initiation by other carcinogenic stimulus, e.g. herpes simplex virus 
type 2 and/or cigarette smoking (18). 
The recognition that human papilloma virus infection is associated with cervical 
precancerous lesions and invasive carcinoma has raised the hope that identification 
of the virus may have prognostic value (23,56). Boon and Fox compared the 
natural course of CIN lesions in 100 women with and without koilocytosis No 
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differences of behavior could be demonstrated during 3-4 years follow-up (17). 
Meisels et al described that nearly 70% of lesions suggestive of HPV infection 
disappeared after a follow-up period of 15 months (68). The significance of HPV 
infection as a progression marker has to be further evaluated by prospective trials. 
Preliminary findings of the HPV studies have not led to a change in attitude 
towards CIN lesions. Bonfiglio and Stoler in an editorial in Human Pathology 
recently stated, that "these lesions should be classified and reported to the degree 
of morphological abnormality present, irrespective of the presence or absence 
of histological or other evidence of HPV infection" (16). Clinical evaluation and 
mode of treatment should be chosen irrespective of evidence of the absence or 
presence of HPV or a specific genotype (16,18,22,56). 
DNA ANALYSIS 
For many years it is known that malignant tumors frequently have chromosomal 
changes. This has recently attracted much attention as a result of three major 
developments. 1) In solid tumors, chromosomal rearrangements, usually transloca-
tions are uncovered, which are based on exchange of material between two, or 
occasionally more, chromosomes following breakage (40). Some of the transloca-
tions appear to be specific and may play a role in the initiation of the neoplastic 
process, as indicated for chromosomes #8 and #14 in the study of Burkitt 
lymphoma (44,100). Genie changes may be mediated by numeric or structural 
chromosomal changes. Numeric changes indicate the gain or loss of whole chromo-
somes. Structural changes are various and include translocations between chromo-
somes and other forms of rearrangement of chromatin. As a result of these 
changes portions of chromosomes may be present in excess or may be deficient. 
The discovery of a shortened chromosome #21 in chronic myelogenous leukemia 
was of special of interest, because it often occurred as the only anomaly in a 
predominantly diploid malignancy. Because of this phenomenon this #21 deletion 
was regarded as strong evidence to link genetic alteration and the etiology of 
cancer. 2) It is suggested that activation of particular genes (oncogenes) is 
important in neoplastic transformation. The function of genes located in the 
vicinity of breakage-points may be modified. Some oncogenes are situated close 
to breakage-points of chromosomes that take part in translocations, as in Burkitt 
lymphoma (44,100). It is believed that the activation of these oncogenes is a direct 
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consequence of their transference to a new chromosomal site following translocati-
on. The activation of oncogenes may be brought about in various ways, e.g. by 
their interaction with viruses (3,44). The increased interest for this type of DNA 
analysis has led to the discovery of many oncogenes and their possible role in 
uncontrolled cell proliferation. 3) The recent descriptions of tumor suppressor 
genes have indicated that loss of genetic functions may furthermore be critical for 
the development of cancer. A finding that was supported by the results of studies 
of restriction fragment length polymorphism's (RFLP's), that showed that specific 
chromosomal deletions are often associated with certain malignancies (62,87,92). 
It has to be stated however that cytogenetic studies of solid tumors, such as 
cervical invasive squamous cell carcinoma and cervical intraepithelial neoplasia, 
still are very complicated and time consuming, and cannot be used in a clinical 
setting. In solid tumors metaphases are relatively infrequent and it is difficult or 
even impossible to obtain good chromosome spreads and satisfactory chromosome 
banding. Furthermore chromosome changes in solid tumors are often very com-
plex. In situ hybridization, a technique, that is developing very rapidly, does allow 
the study of complete chromosomes and details of chromosomes in interphase 
nuclei in frozen sections, and in paraffin-embedded sections. This technique has 
the potential to become clinically applicable (24,45). 
Other techniques to study DNA changes which may become applicable in a 
clinical setting, are DNA ploidy analysis and high resolution DNA cytophotometry, 
based on measurements of cells stained with DNA-specific stains, such as the 
Thionin-Feulgen stain (73). 
DNA ploidy analysis. 
It is generally accepted that a developing tumor has a dominant stemline with a 
particular karyotype, within which variants are continually being produced. Many 
of these variants will not survive while others may remain viable and are directly 
related to more malignant properties of the tumor. This proces continues during 
lifetime of the tumor and may give rise to subclones, which predominate in certain 
regions of the tumor or may even take over as a new stemline. It is possible for 
the entire (or for part of the) chromosome complement to be doubled in some 
regions of the tumor. The result of this polyploidization may be the emergence 
of a stemline with a high basic chromosome number in the triploid or tetraploid 
region. As the proces of polyploidization continues a subpopulation of cells with 
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the double number or higher multiples of the basic chromosome number may 
develop. It is suggested that a tumour cell line with double the original chromoso­
me set becomes dominant and that loss of chromosomes then produces the 
hypotetraploid values which are thought to be common in cancer (3). DNA 
ploidy analysis can be performed by flow cytometric and image cytometric (cyto-
photometric) techniques. Flow cytometry allows DNA ploidy analysis of a large 
number of cells in a short time, but it is not possible to study chromatin texture 
or geometric features of individual cells in detail. Image cytometric analysis also 
allows DNA ploidy analysis, but may also give information of the chromatin 
pattern and geometry of the nuclei. The number of cells that can be measured 
are limited and the speed of measurements is still lower. 
The flow or image cytometric DNA ploidy patterns can be visualized by histo­
grams displaying the amount of DNA present in the stemlines (42). The histo­
grams may be assessed as DNA-dipIoid, DNA-poIyploid and DNA-aneuploid 
patterns, according to the following definitions (7,41,42). In a diploid(like) pattern 
a distinct G0/G1 peak (corresponding to cells in rest phase of the cell cycle) is 
found in the (near-)diploid (2C; 0.9<DI<1.1) region with a small proportion of 
cells in S mode (corresponding to the synthesis phase) and in G2/M mode 
(corresponding to the G2 phase and mitotic phase), a pattern which is very similar 
to that of normal tissue. In polyploidy distinct peaks are present in the diploid 
and tetraploid (4C; 1.8<DI<2.2) regions, or in the diploid, tetraploid and oc-
taploid (8C; 3.6<DI<4.4) regions. Very few cells or none at all have DNA values 
corresponding to the DNA synthesis phase of normal cells. In all other cases 
ploidy patterns are considered aneuploid. 
An additional description of the DNA content of a population of cells may be 
obtained by the calculation of the 2.5c and 5c exceeding rates. These are defined 
as the percentages of cell nuclei having DNA values higher than 2.5c (1.25 χ 
normal diploid amount of DNA) respectively higher than 5c (2.5 χ normal diploid 
amount of DNA) (15,71). 
DNA ploidy patterns in nonna! tissues. 
The normal tissues of the body are composed of cells with multiples of the 
haploid chromosome set. The gametes are haploid, most other cells are diploid, 
a few are tetraploid and other multiples going in powers of two (like megakaryo­
cytes). It is assumed that loss of chromosomes, that may be encountered some­
times in normal tissue can be explained by loss during the technical preparation 
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of the tissue (3,91). In bone marrow however chromosome loss (e.g. 45 instead 
of 46 chromosomes) is seen with advancing age. Spnggs stated that apart from 
chromosomal loss and the presence in the same tissue of polyploid cells, there 
is no reason to suspect that deviations from the normal karyotype commonly occur 
(91). 
DNA ploidy patterns in cervical invasive carcinoma. 
As already stated, a complete karyotypic analysis of cervical tumors is frequently 
impossible because of technical difficulties. Nevertheless it was shown that numeri-
cal changes occur in cervical cancer, and although being extremely variable, they 
appeared to be non-randomly distributed (2,90). Thus it could be determined that 
certain chromosomes were especially involved in structural or numerical changes: 
Chromosome #1 : excess of part of the long arm or of the whole chromosome 
in a near-diploid tumor; Chromosomes #3, #6, #17: often structural changes, 
Chromosome #11: structural changes or deletion of chromosome. Several tumors 
had small abnormal metacentric marker-chromosomes of uncertain origin. (3,5,6, 
49,94). Jones, using the direct squash technique on cervical biopsies of four cases 
of squamous cell carcinoma, reported that the modal number was in the diploid 
(47) range in one case and in the near-tnploid (65-67 chromosomes) range in the 
other three cases (49). Vang Nielsen indicated that errors in chromosome counting 
procedures are likely to occur and that cytometric DNA ploidy analysis may 
overcome this problem by measuring the relative DNA content of all cells in the 
specimen (94). Most ploidy analysis studies were performed by cytometric techni-
ques. In a cytometric DNA ploidy analysis study of 468 cases of cervical invasive 
squamous cell carcinomas, Atkin demonstrated that just over half the cases tell 
into a near-diploid group and just under half into a triploid-tetraploid group (3). 
Of patients with near-diploid tumors 39% survived 5 years, ot those with near-
triploid and -tetraploid tumors 48%. Atkin raised the possibility that tumors with 
high modal values might be more radiosensitive (3,4). Jakobsen described the 
flowcytometric analysis of 171 cases of cervical invasive carcinoma, indicating that 
the rate of recurrence was highest in tumors with a DNA index >1.5 and that 
survival was highest with a DNA index <1.5 (47). Also Goppinger and coworkers 
could not confirm Atkin results. In a cytomorphometnc study of cervical smears 
of 30 patients with squamous cell carcinoma, four patients with diploid and 6 with 
polyploid tumors were all alive after 10 years follow-up. Of the 20 cases with 
an aneuploid DNA pattern 14 had died and three were alive after 10 years follow-
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up (32). Cervical carcinomas in the study by Atkin, tended to be more often near-
diploid in younger patients, and more often near-triploid and -tetraploid in older 
patients (3). Also Strang and coworkers found age related differences in patients 
with squamous cell carcinomas; in patients of 35.6 (+/- 11.7) years of age tumors 
mostly had a diploid or polyploid DNA pattern and in patients 73 (+/- 12.6) years 
of age tumors were grossly aneuploid (93). 
DNA ploidy patterns in cervical intraepithelial neoplasia. 
Few chromosome studies have been performed in CIN lesions, mostly on un-
handed preparations. In a study of 58 lesions Aktin demonstrated the presence 
of chromosome abnormalities and of cell clones with DNA values in the near-
triploid or near-tetraploid region, as well as in the near-diploid area (3). Jones 
and coworkers reported the results of six cases of CIN using the direct squash 
technique. Three of these had a diploid (46-47 chromosomes) modal number of 
chromosomes, and in the other three cases a near-tetraploid (86-94 chromosomes) 
pattern was present (49). Spriggs and coworkers studied 28 cases of CIN and 
microinvasive carcinoma, and concluded that no chromosomal feature was distinc-
tive of dysplasia, carcinoma in situ, microinvasive or invasive carcinoma (89). 
Spriggs and Atkin, both mentioned that marker chromosomes appeared to be 
infrequent, but stated that these are possibly more frequent in lesions that have 
progressed to the microinvasive stage (3,89). In a study in which banding techni-
ques had been used, abnormal chromosomes were seen in two cases of carcinoma 
in situ (3). In both lesions abnormal chromosomes #1 were observed. In a case 
of microinvasive carcinoma an isochromosome #17 was noted. Atkin mentioned 
furthermore that carcinomas in situ may have undergone less chromosomal loss 
and fewer structural changes than invasive cervical carcinomas. 
Microspectrophotometric, flow and image cytometric DNA ploidy measurements 
have been performed in cervical scrapings, fresh biopsy material and paraffin 
sections (3,12,13,14,28,29,37,46,71,69,85,98). Jakobsen and coworkers performed 
flow cytometric analysis of cervical biopsies and found that a DNA-aneuploid 
pattern was present in 7% of CIN I and II lesions and in 79% of CIN III lesions 
(46). Wilbanks and coworkers in an earlier report using two-wavelength Feulgen 
cytophotometry of cervical biopsies, mentioned that the degree of deviation from 
the DNA-diploid pattern of normal epithelium was least in mild dysplasia and 
became more pronounced in the higher grade lesions (98). In a (microspectropho-
tometric) study of cervical smears consistent with moderate dysplasia Nasiell and 
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coworkers could however not find significant differences between those cases that 
progressed to carcinoma in situ and those that regressed to normality (67). In a 
more recent paper Nasiell et al reported on a group of nine patients with cervical 
smears representing mild or moderate dysplasia, and showed that progression to 
carcinoma in situ was accompanied by a sequence of increasingly abnormal DNA 
patterns. In three patients with cervicitis as the final diagnosis, DNA patterns were 
within normal limits (71). Some investigators have implied that cervical intraepithe-
lial lesions with an aneuploid DNA pattern have higher rates of persistence or 
recurrence than lesions with a diploid or polyploid pattern (13,29). The results 
of these studies seem to be in conflict with the DNA analyses showing (peri)-
diploid or a low ploidy DNA patterns in more than 50% of micro- and macro-
invasive squamous cell carcinomas (4,47). Invasive carcinomas with a low ploidy 
pattern were further reported to have a higher frequency of lymph node metasta-
ses than occurred in high-ploidy carcinomas of comparable size and depth of 
invasion (2,4,47). Therefore, more studies would have to be carried out before 
a new classification of Cervical Intraepithelial Neoplasias could be based on DNA 
ploidy pattern analysis. 
High resolution cytophotometric analysis. 
The cytological and histological diagnosis of malignancy is mainly based on changes 
in nuclear characteristics, such as differences in nuclear size, shape and chromatin 
distribution. The chromatin consists of DNA that forms a complex with proteins, 
mainly histone and non-histone proteins. The distribution of nuclear chromatin 
reflects the distribution of chromosomes, and as such the distribution of DNA 
throughout the nucleus (24). Cytologically in tumor cells an increase of heterochro-
matin, that reflects the compact chromatin, can be observed as a coarsening of 
the chromatin pattern. 
Using a scanning microscope the chromatin texture, density and geometry of nuclei 
can be measured. Nuclei, processed with a specific Feulgen DNA stain, can be 
raster scanned by a finely focused light spot and stored as arrays of numbers in 
a computer system. Each number expresses the amount of light absorbed at the 
corresponding picture element or "pixel", and thus is a measure of the local DNA 
content. Differences in grey level between object and background be studied. 
Boundaries of the nuclei can be automatically determined from the digital image 
by grey level boundary following. Nuclear features, describing geometrical, density 
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and texture characteristics may be extracted from the digitized image (8,9,30,39,74,-
80) Cytophotometric analysis has been of value in the study ot cervical intermedi-
ate cells as present in cytological smears containing normal, dysplastic and carcino-
ma in situ cells, in studies ot normal and malignant endometrium, in the differen-
tial diagnosis in pleural ettusions and in the discrimination between classic and 
variant type small cell lung cancer cell lines (11,19,50,73,74,97). An advantage of 
DNA-cytophotometric analysis is that interphase tumor cells can be measured, 
providing objective information of chromatin distribution, which is an expression 
ot chromosomal changes. Furthermore an implicit advantage of the high resolution 
cytophotometncal analysis is that large samples of digitized nuclei can be compa-
red by sophisticated statistical techniques. 
OUTLINE OF THE STUDY 
The aim ot the study was to investigate the potential of combined DNA ploidy 
analysis and high resolution cytophotometric analysis to discriminate between 
progressive and non-progressive cervical intraepithelial neoplastic lesions. Chapter 
2 describes a technique to perform flow and image cytometric analysis on selected 
areas in parattin-embedded tissues. This technique creates the possibility to study 
archival material in detail. Chapter 3 reports the application of flow and image 
cytometric DNA ploidy analysis, using this technique, on a group of paratfin-
embedded CIN III lesions, in part with and in part without synchronous cervical 
invasive carcinoma. In chapter 4 DNA ploidy analysis and high resolution cytopho-
tometric image analysis are performed in a group of CIN III lesions and a group 
ot cervical invasive squamous cell carcinomas. Chapter 5 describes the application 
ot high resolution cytophotometric analysis in CIN III lesions with and without 
synchronous cervical invasive carcinoma, in an ettort to make a subdivision in 
potentially progressive and non-progressive CIN lesions. Chapter 6 compares the 
results ot DNA ploidy analysis, 2.5c and 5c exceeding rates and high resolution 
cytophotometric analysis in CIN III lesions trom cytological smears and in cytospin 
specimens, retrieved trom selected areas in parattin-embedded tissues. Chapter 
7 reports the application ot DNA ploidy analysis, 2 5c and 5c exceeding rates and 
high resolution cytophotometric analysis in cytological smears, representing a group 
ot progressive CIN I-III lesions and a group of CIN III lesions with unknown 
outcome. 
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Abstract A method for the extraction of nuclei from selected regions in paraffin-
embedded tissue is described. Fifty-micrometer sections are cut, dewaxed, and 
rehydrated. For the final handling, the sections are manually transferred from one 
tray to another. The sections are put on a slide under a dissection microscope 
and the region of interest is isolated by scrapping off the irrelevant region with 
a scalpel. An optimal number of single nuclei is obtained by incubation in a 
protease solution with intermediate syringing. The nuclei are washed and can be 
used for flow cytometry. Resuspension of the nuclei in foetal calf serum and 
cytocentrifugation results in preparations suited for image analysis. DNA cytometric 
measurements of nuclei in a carcinoma in situ and an invasive carcinoma region 
in breast tissue present in the same tissue block and in a severe dysplasia/carcin-
oma in situ (CIN III) region of the cervix are presented. 
INTRODUCTION 
The method for extracting nuclei from archival paraffin-embedded tissue (1,2,7-
9) has made retrospective studies on large series of patient material possible. By 
the use of this method, nuclei are isolated from thick (30-100 μηι) sections and 
used both for flow (1,2,7,8) and image (9) cytometry. With this method the 
correlation between the DNA content of tumor cells and the prognosis (3,4) for 
a number of malignancies has been determined. In addition to the use of this 
method in retrospective studies, it has other advantages. The cell composition of 
the thick tissue section is known beforehand by visual inspection of haematoxylin-
eosin (H-E)-stained 4-7 μτη sections cut before and after the thick section(s). This 
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check for cell composition avoids sampling errors and can also be used to select 
regions of interest. For instance, stromal and necrotic tissue in tumors, interfering 
with the measurements, can be eliminated in advance. Furthermore, nuclei from 
morphologically different regions in the tissue can be extracted. 
This study explores the latter possibility. A method for isolating nuclei from well-
defined regions in paraffin-embedded tissue is described. The method has been 
applied to breast and cervical tissue. Quantitative DNA measurements in nuclei 
obtained from these regions are shown as an example. 
MATERIALS AND METHODS 
Paraffin-embedded tissue was cut according to the following sequence: 5 μτη, 
2 χ 50 μπ\, 5 μιη, 2 χ 50 μτη, etc. The number of sequences was determined by 
the number of thick sections desired. The 5 д т sections were H-Ε stained and 
served as a control for cell composition. During the cutting of the thick sections, 
care was taken that they remained stretched, since once rolled up it was difficult 
to stretch them again. The sections were put into a small, round, stainless sieve 
(3 cm diameter, 1 cm high) with a nylon mesh with 100-дт holes in the bottom. 
They were dewaxed and rehydrated according to the following sequence: xylene 
(twice), 100% ethanol (twice), 80% ethanol, 70% ethanol, 50% ethanol, and 
distilled water. The sieves with the sections were put in petri dishes and kept for 
at least 10 min in each solution. Thereafter the sections were put on a slide. With 
the aid of the H-E-stained 5 д т sections, cut before and after the 50 д т sections, 
the cell composition and architecture in the thick sections were known. Together 
with this information as well as the microscopically observed tissue-cell architecture 
in the unstained thick section the area of interest was identified. Under a dissecti­
on microscope the irrelevant areas was scraped off with a scalpel and discarded. 
The tissue of interest was then scraped off and put into a centrifuge tube. The 
sections were incubated in phosphate-buffered saline (PBS; 137 mM NaCl, 13 mM 
Na2HP07-2H20, 3 mM КНгРО,,, pH = 7.4) with protease (Type VII from 
Bacillus amylolique faciens, Sigma Chemical Co., St Louis, MO) at 37"C. For 
breast tissue a 0.05% protease concentration and a 30-min incubation time were 
used. For cervical tissue a 0.1% protease concentration and a 60-min incubation 
time were used. 
During incubation the sections were gently syringed at 15, 30, 45 and 60 min 
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with needles ranging in diameter from 1.1 mm to 0.4 mm. Incubation was termina­
ted by adding 4-5 ml cold (40C) PBS, after which the tubes were put in ice. The 
nuclei were washed twice with PBS with intermediate centrifugation steps. The 
nuclei were counted with a Coulter Counter Model ZB1 (Coulter Electronics, 
Hialeah, FL). For cervical tissue about 10,000 nuclei were centrifuged, the 
supernatant was discarded, and 150 μΐ foetal calf serum (normal pooled; Gibco, 
Paisly, U.K.) was added. The pellet was resuspended and placed on a slide with 
a cytocentrifuge apparatus (Shandon, U.K.; 10 min χ 500 rpm). The slides were 
briefly (10-20 s) air-dried and fixed in a methanol 37% formaldehyde-acetic acid 
mixture (85:10:5 by volume) for 1 h. They were then Thionin-Feulgen stained and 
measured for DNA content (200 nuclei/slide) as described elsewhere (6). 
For breast tissue enough nuclei were taken to prepare a slide foi Thionin-Feulgen 
staining and measurement (150 nuclei/slide). The remainder of the nuclei was 
centrifuged and fixed in cold (-2(fC) 70% ethanol. The nuclei were then stained 
for DNA with propidium iodide (5) and measured in a cytofluorograph system 
50H flow cytometer (Ortho Instruments,Westwood,MA). 
RESULTS 
Figure 1 shows an example of nuclei of a severe dysplasia/carcinoma in situ 
(CIN III) region of the cervix, prepared according to the standard procedure. As 
can be seen the chromatin texture is well preserved. 
Figure 2A shows a picture at low magnification of а 5-дт section of a breast 
tumor. The upper portion was diagnosed as an invasive lobular breast carcinoma 
(see Fig. 2B) and the lower part was diagnosed as lobular carcinoma in situ (CIS) 
(Fig. 2C). Figure 3a shows a DNA histogram obtained by flow cytometry and 
Figure 3d shows a DNA histogram obtained by image (scanning) cytometry of 
nuclei from the entire (nonselected) thick tissue section cut after the 5-μηι section 
shown in Figure 2A. As can be clearly seen in both figures, aneuploidy is present. 
Figure 3b shows a flow DNA histogram and Figure 3e shows an image DNA 
histogram of the cells from the CIS region. In this case diploidy is found. DNA 
histograms of the invasive carcinoma region are shown in Figure 3c (flow) and 
3f (image). Here again, as in Figure 3a, aneuploidy is observed. 
34 
~" 
Figure 1: Isolated nuclei from a severe dysplasia/carcinoma in situ (CIN III) region of the 
cervix, prepared according to the standard procedure (Thionin-Feulgen stain, x660). 
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Figure 2 A: Microscopic picture at low (x21) magnification of a lobular breast carcinoma with 
an invasive carcinoma (top, above the arrows) and a CIS (bottom) region. 
B: Picture at high (x430) magnification of the cells in the invasive carcinoma region 
of A. 
C: Picture at high (x430) magnification of the cells in the CIS region of A. 
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Figure 3: Propidium iodide DNA flow cytometry (a-c) and Thionin-Feulgen DNA image 
(scanning) cytometry (d-f) of the breast carcinoma in Figure 2. a and d are histo­
grams of the entire section, b and e are from the CIS region, and с and f are from 
the invasive carcinoma part. 
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Figure 4A shows a picture at low magnification of cervical tissue with CIN III 
on the surface (between the arrows) and stromal tissue underneath, composing 
more than half of the total tissue block. Figure 4B shows the cells of the CIN 
III region at higher magnification. 
Figure 4: Microscopic picture at low (xl5) magnification of cervical tissue with a CIN III region 
(between the arrows, at the surface). B. Picture at high (x76) magnification of the CIN 
III cells in A. 
Figure 5a shows an image (scanning) cytometric-derived DNA histogram of nuclei 
from the entire thick section. As can be seen, diploidy is observed with some 
aneuploid cells. Figure 5b shows a DNA histogram of the nuclei obtained from 
the CIN III region. A peak at 140 arbitrary units (A.U.) and a second at 280 
A.U. can be observed. The nuclei were measured at random, thus including nuclei 
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of leukocytes and some stromal cells (fibroblasts). Since in scanning cytometry the 
nuclei can be visually inspected before measurement, clearly non-CIN III cells, 
such as leukocytes, can be omitted. Therefore, a third histogram (Fig. 5c) was 
constructed, in this case with the omission of leukocytes. A contamination in this 
histogram with some stromal cells is still possible. It was not possible to formulate 
morpholocial criteria to distinguish these'from some oval- and longshaped CIN 
III cells. 
Figure 5 A-Thionin-Feulgcn DNA image (scanning) cytometric histogram of all nuclei of the 
entire section shown in Figure 4A. В DNA histogram of all nuclei in the CIN III 
region. С DNA histogram of all nuclei in the CIN III region, with the omission of 
leukocytes. 
DISCUSSION 
In this paper a nuclear preparation method is evaluated that prepares nuclei 
from (small) selected areas in paraffin-embedded tissue. After testing different 
enzymes, e.g., pepsin (1,2), trypsin (7), and protease (9), the latter was found 
38 
to be optimal. Pepsin and trypsin could be used when only flow cytometric DNA 
measurements were performed. However, when nuclei had to be put on slides 
for image analysis measurements, it appeared that the chromatin texture was 
disrupted by these enzymes. Protease resulted in nuclei of optimal morphology 
(Fig. 1). These results agree with those found by Van Driel-Kulker et al. (9). Flow 
cytometric DNA measurements after protease treatment were comparable to those 
found with pepsin or trypsin (results not shown). 
The concentration and incubation time for the protease treatment were different, 
depending on the tissue type. For cervical tissue both concentration and incubation 
time had to be doubled compared to that for breast tissue. A concomitant 
syringing procedure was necessary for an optimal number of single nuclei for both 
tissues. These results differ from those reported by Van Driel-Kulker et al. (9). 
They reported that a fixed concentration and incubation time without syringing 
was sufficient for an optimal number of nuclei for the different tissue types they 
tested. 
As can be concluded from the results, more information is available when measu-
rements in nuclei from selected regions are performed than in nuclei from the 
whole thick tissue sections. In the examples of the breast tumor, the information 
that the CIS region is diploid (Fig. 3b,e) and the invasive carcinoma part aneu-
ploid (Fig. 3c,f) is lost when nuclei from the whole section are measured (Fig. 
3a,d). It should be stressed that in this example the CIS part is diploid and the 
invasive carcinoma part aneuploid; this does not have to be a general phenome-
non. 
In the example of the cervical tissue, not much information is present in the 
DNA histogram of the entire tissue (Fig. 5a); only some aneuploid cells are 
detected. When the nuclei from the CIN III region are measured randomly, a 
DNA histogram is obtained that is clearly interpretable (Fig. 5b). A first diploid 
peak is found at 140 A.U. while a second tetraploid peak is found at 280. The 
cells with higher DNA values are probable cells in S and G2M phases of the 
tetraploid population. Most likely all CIN III cells are tetraploid as can be 
concluded from the histogram in Figure 5c. The small diploid peak at 140 A.U. 
is most probably from stromal cells that cannot be distinguished from CIN III 
cells. 
The procedure as described in this paper is now in routine use in our laboratory. 
In most breast tumors, enough tissue is available to perform both flow and image 
cytometry. For the cervical tissue, too few nuclei are obtained from most CIS 
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regions to perform flow cytometry but are sufficient to perform image analysis. 
The method, as described in this paper, has been illustrated by quantitative DNA 
measurements on nuclei extracted from these regions. However, more types of 
measurements are possible: for instance, multiparameter flow cytometry as well 
as image analysis measuremets of the size, shape, and texture of the nuclei. 
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DNA PLOIDY PATTERNS IN 
CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE III, 
WITH AND WITHOUT 
SYNCHRONOUS INVASIVE SQUAMOUS CELL CARCINOMA 
Measurements in nuclei isolated from paraffin-embedded tissue 
A.G.J.M. Hanselaar, MD, G.P. Vooijs, MD, PhD, P.S. Oud, PhD, 
M.M.M. Pahlplatz, MS, and J.L.M. Beck, CT. 
Abstract This study presents the results of cytophotometric (CPM) and flow 
cytometric (PCM) DNA ploidy measurements in cervical intraepithelial neoplasias 
grade III (CIN III) with and without synchronous invasive squamous cell carcino-
ma. Hysterectomy and biopsy material from 21 patients 35 years of age or 
younger and from 18 patients age 50 years or older was studied. The DNA 
analysis was performed in nuclei isolated from specific areas of paraffin-embedded 
tissue. There were significant differences in the distribution of DNA patterns 
between the two age groups. About 80% of CIN III lesions in women 50 years 
of age or older, with or without a coexisting invasive cancer were aneuploid. In 
the group of younger women a diploid DNA pattern was found in about 60% of 
CIN III with concomitant invasive cancer. In the absence of an invasive cancer, 
CIN III lesions were mostly polyploid. The DNA pattern of invasive cancers was 
generally identical with the adjacent CIN, thus suggesting that the two lesions were 
related. Although the prognostic value of DNA ploidy measurements in cervical 
intraepithelial lesions in women in these two age groups has to be further evalua-
ted, these results are at considerable variance with previously published data on 
DNA values in CIN and invasive carcinoma. In four CIN III lesions without 
invasive cancer, in women of the group of 35 years of age or younger, human 
papilloma virus common antigen could be demonstrated by immunochemical 
procedure. In three of these cases a polyploid DNA pattern was present; the 
fourth case showed a bimodal aneuploid pattern. 
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INTRODUCTION 
Epidemiologic studies of cervical neoplasia have shown the incidence of carcinoma 
m situ and related lesions, grouped as cervical intraepithelial neoplasia grade III 
(CIN III) to be much higher than the incidence of invasive squamous cell carcino-
ma (ISC), indicating that only a relatively small number of CIN III lesions will 
progress to invasion. The majority of CIN III lesions, therefore, will either regress 
or persist (1-3) Biopsies or treatment may account for some, but not all, of these 
cases (4-5). 
It is not possible to separate CIN III lesions into regressive, persistent, or progres-
sive subtypes purely on the basis of histologic, cytologic, or clinical criteria The 
use of objective parameters such as DNA measurements is being given increasing 
attention (6-13). Aneuploidy has been a frequent finding in CIN III lesions using 
chromsome analysis (6-7), cytophotometnc (CPM) or flow cytometric (FCM) DNA 
measurements in cervical scrapings (8,9), fresh biopsy material (10), or paraffin 
sections (11,12) 
Cervical intraepithelial lesions with an aneuploid DNA pattern have been reported 
to have higher rates of persistence or recurrence than lesions with a diploid or 
polyploid pattern (8,11,12). The results of these studies seem to be in conflict with 
DNA analyses which showed (pen-) diploid" or low ploidy DNA patterns in more 
than 50% of micro and macroinvasive squamous cell carcinomas (13,14) Invasive 
carcinomas with low ploidy pattern were reported to have a higher frequency of 
lymph node metastases than occurred in high-ploidy carcinomas of comparable 
size and depth of invasion (6,8,13,15) Furthermore, it was stressed by Atkin (15) 
that a diploid DNA pattern does not necessarily indicate a favorable outcome. 
Recently the role of human papilloma virus (HPV) infection in the pathogenesis 
of cervical neoplasia has attracted much attention. Along with koilocytotic atypia, 
which has been accepted as a pathognomonic cytologic marker for HPV mfection 
(16-19), HPV DNA can be demonstrated in most cases of cervical intraepithelial 
neoplasia and ISC using molecular hybridization techniques (20-24). V/ith immuno-
histochemical techniques, the presence of the common viral capsid antigen could 
be documented in some cases of cervical intraepithelial neoplasia, but not in 
invasive squamous carcinoma (24-26) The DNA ploidy pattern of the lesions 
associated with HPV was studied by Fu and co-workers (12,27). They stated that 
typical condylomas without a significant degree of nuclear pleomorphism have a 
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polyploid DNA distribution, whereas "those changes having an aneuploid DNA 
pattern are true neoplastic processes". 
This article reports the results of DNA measurements performed on whole nuclei 
derived from specific areas of the uterine cervix identified under the microscope. 
The method used in this study allowed us to compare the DNA content in 
intraepithelial lesions classified as CIN III without adjacent invasive cancer (CIN) 
with the DNA content in CIN Ill-like lesions adjacent to invasive cancer (CIN-
INV). Furthermore, we compared the DNA content in intraepithelial CIN III-
like lesions adjacent to areas of invasive carcinoma with the DNA content of 
the invasive component. The study was performed on two groups of women: age 
35 years or younger and age 50 or older, corresponding to the biphasic distributi-
on of invasive carcinoma (2,3). In all patients representative histologic sections 
were stained for the presence of papilloma virus common antigen. 
PATIENTS AND METHODS 
Patients 
In this study cervical tissue derived from hysterectomy and biopsy material of 
39 patients was examined. The CIN III was defined as an epithelial lesion in 
which undifferentiated basal or parabasal cells with nuclear enlargement, crowding, 
indistinct cell boundaries, and a high nucleo-cytoplasmic ratio occupied more than 
two thirds (or the full thickness) of the epithelium (28). Superficial cytoplasmic 
keratinization could be present. 
The lesions were divided into separate groups, according to age of the patients 
and the presence or absence of invasive cancer adjacent to intraepithelial neopla-
sia (Table 1). 
The first group contained 11 cases of CIN III in patients 35 years or younger, 
without concomitant microinvasive or macroinvasive squamous cell carcinoma 
(I:CIN). The second group (IIA and IIB) consisted of ten patients also 35 years 
of age or younger, but with CIN III lesions (IIA:CIN.INV) and an invasive 
carcinoma (IIB:INV) directly related to the CIN lesions in the same or in an 
adjacent tissue block. 
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Table 1. Cervical epithelial abnormalities, subdivided for type of lesion and age. 
Cervical Intraepithelial neoplasia 
grade 3 without adjacent invasive 
carcinoma (CIN) 
Cervical intraepithelial neoplasia 
grade 3 with adjacent invasive 
carcinoma (CIN.INV) 
Invasive squamous cell carcinoma 
adjacent lo CIN 3-like lesions 
(INV) 
Total 
S 35 
Pat. 
ΕΦ 
I 
IIA 
IIB 
Ж 
Lsn. 
Ν 
11 
10 
10 
31 
Pat. 
Ν 
11 
10 
21 
> 50 vr 
Pat. 
grp 
III 
IVA 
IVB 
Lsn 
N 
8 
10 
10 
28 
Pat. 
N 
8 
10 
18 
The CIN III lesions with or without concommitant invasive cancer were morpholo­
gically identical. However, the biological behavior is likely to be different. To 
differentiate between these two lesions we introduced for CIN III lesions with 
concomitant invasive cancer the term CIN Ill-like lesions (CIN.INV). Eight women 
50 years or older with CIN III, without a concomitant invasive cancer constituted 
the third group (IILCIN). 
The fourth group was composed of ten women, 50 years or older, with CIN Ill­
like lesions (IVA:CIN.INV) and an invasive cancer in the same or in an adjacent 
tissue block (IVB:INV). 
Using a recently described method for extracting intact nuclei from paraffin-
embedded tissue (29-31), it is possible to perform image and FCM DNA measure­
ments of preselected areas in tissue sections. 
Thus using selected areas, DNA content of pure intraepithelial lesions (CIN) 
can be compared with DNA content of intraepithelial lesions directly adjacent 
to invasive squamous cell carcinoma (CIN.INV) (Fig. 1). Also, the DNA content 
of invasive carcinomas (INV) can be compared with DNA content of both types 
of CIN III (CIN and CIN.INV). 
Method of extraction of nuclei from paraffin-embedded tissue 
Two consecutive 50-дт sections were cut from paraffin-embedded formalin-fixed 
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tissue containing CIN III and/or invasive cancer. Fifty micrometers' thickness was 
proven to cause the least number of artifacts in DNA histograms (32). Sections 
were deparaffinized and rehydrated in the following sequence: xylene (twice), 
100% ethanol (twice), 80% ethanol, 70% ethanol, 50% ethanol and distilled water 
(at least 10 minutes in each solution). Thereafter tissue sections were placed on 
microscopic slides. For orientation and localization of relevant areas δ-μτη tissue 
sections were made before and after the two "thick" sections were cut. These were 
stained with hematoxylin and eosin (H&E). An example of a CIN Ill-like lesion 
with an adjacent invasive carcinoma is shown in Figure 1. 
В 
,U 
Figure 1: Invasive squamous carcinoma (B) and an adjacent CIN III (A) (H & E, x4). 
Under a dissecting microscope the CIN III and/or invasive carcinoma regions were 
localized and prepared for DNA analysis by scrapping off nonrelevant areas with 
a scalpel. The target tissue was then taken from the glass slides, put in a centrifu­
ge tube, and incubated in phosphate-buffered saline (PBS), with 0.1% protease 
(type VII from Bacillus amylolique faciens, Sigma Chemical Co, MI) at 37°C, for 
60 minutes. During incubation the specimens were gently syringed using needles 
ranging in diameter from 0.4 to 1.1 mm (gauge, 23-19), at 15, 30, 45, and 60 
minutes. Incubation was terminated by adding 4 to 5 ml of cold (4°C) PBS, 
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after which the tubes were put on ice. The nuclei were washed twice with PBS 
with intermediate centrifugation steps, and counted with a Coulter Counter Model 
ZB1 (Coulter Electronics, Hialeah, FL). About 10,000 nuclei were centrifuged, 
and 150 μΐ fetal calf serum (normal pooled Gibco, Paisly, UK) was added. This 
cell suspension then was centrifuged (5 minutes at 500 rpm), placed on slides 
using a cytocentrifuge (Shandon, UK) for 10 to 20 seconds, air dried, and fixed 
in a mixture of methanol, 37% formaldehyde, and acetic acid (85-10-5 by volume) 
for 1 hour. 
Cytophotometrìc analysis 
For CPM isolated nuclei from tissue blocks of all 39 patients were stained with 
Thionin-Feulgen (33). DNA content of 200 stained intact CIN III (CIN and 
CIN.INV) or invasive cancer (INV) nuclei was measured using the Nijmegen 
Image Analysis System (NIAS). The NIAS system is composed of an Orthoplan 
Scanning microscope (Leitz Wetzlar, West Germany), and provided with a linear 
diode array (Fairchild). The microscope is interfaced to a MINC minicomputer 
with a LSI 11/23 microprocessor (Digital Equipment Corp., Maynard, MA). Nuclei 
were measured with monochromatic light with a wavelength of 585 nm (band 
width, 20 nm). Sampling density was four pixels per micrometer. As an internal 
standard for DNA content 20 lymphocytes per slide were measured. 
Flow cytometric analysis 
The suspension containing residual nuclei was centrifuged briefly and fixed in 
cold (-20oC) 70% ethanol. 
The nuclei were then stained for DNA with propidium iodide (34) and measured 
in a Cytofluorograph 50H flow cytometer (Ortho-Instruments, Westwood, MA). 
In seven patients the number of cells was sufficiently high for both CPM and 
FCM analysis. 
Histogram interpretation 
The DNA content was expressed as DNA index (DI). DNA index was defined 
as the nuclear integrated optical density of the dominant peak or peaks of the 
histogram divided by the median integrated optical density of the "internal" 
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control sample of lymphocytes (35,36). In cytophotometry the DI distributions 
were defined from histograms using a bin size of 0.1. Histograms were classified 
as diploid, polyploid, or aneuploid (11,31). DNA ploidy patterns were designated 
diploid (2C;DI=1.0), when a distinct peak was found in the diploid or near diploid 
(DI-0.9-1.1) region, polyploid when distinct peaks were present either in the 
diploid (2C;Ol=1.0), and tetraploid (4C;DI=2.0) or in the diploid, tetraploid and 
octaploid (8C;DI=4.0) regions. Ploidy patterns were considered to be aneuploid 
in all cases with scattered, unimodal, bimodal, or multimodal distribution of DNA 
peaks in the histograms. 
Identification of papilloma virus infection 
In all cases of CIN III and invasive cancer the presence of papilloma virus 
infection was studied. Paraffin sections (5-6 μπι) were cut from the same tissue 
blocks and submitted for immunohistochemical staining with rabbit antisera, 
prepared against disrupted bovine papilloma virus type 1 virions (Dako Corporati­
on, Santa Barbara, CA). These antisera react with the capsid antigens of both 
animal and human HPV (25-27). Immunohistochemical identification of papilloma 
virus common antigen was performed using the peroxidase-antiperoxidase (PAP) 
technique. Paraffin sections were deparaffinized, hydrated, treated with hydrogen 
peroxide in methanol, rinsed in PBS, preincubated for 10 to 30 minutes in normal 
swine serum, then incubated overnight with the antiserum, diluted 1:3000. The next 
day the specimens were treated with swine anti-rabbit (1:30) and PAP (1:100), 
and visualized with diamine benzidine (DAB). Slides with deep brown nuclei in 
two successive stainings were scored as positive for papilloma virus common 
antigen (25). 
RESULTS 
Comparison of flow cytometric with cytophotometric findings 
In seven patients with invasive squamous carcinoma but in none of the CIN III 
cases, sufficient material was available for FCM DNA analysis. In all seven cases, 
results of FCM and CPM analyses were similar. Two examples are shown in 
figures 2A through 2D. 
48 
2763 τ 
ü 
, , , . ^ ' " Т " ' ^ " ^ ' Ι Р ' 
O i" 3 ' τ 5 2 С 2 ' 
PtRCINTeŒ 
4 0 »5 5 ] ; * б с 6 5 ^ e ' ; з с β 50 100 150 200 250 
FLRA А 
( к о і і й і ^ г а г ^ е ^ 5 * э 4 ^ 5 0 5 , б 0 б 5 ' 0 , 5 100 150 
FLRA А 
»iiMiftp V 
2 0 0 
Figure 2A-2D: Diploid DNA pattern of an invasive squamous cell carcinoma is shown in both 
cytophotometry (CPM) (A, top left) and flow cytomctiy (FCM) (B, top right). 
The DNA index is shown on the X axis in cytophotometry histogram (woman 
31 years of age). (C, bottom left) Cytophotometric (left) and (D, bottom right) 
flow cytometric histograms of an invasive cancer showing a polyploid DNA 
pattern. The first (diploid) peak is higher in the FCM histogram, because 
lymphocytes and stroma cells are measured as well (patient 31 years of age). 
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Cytophülometnc results 
Cytophotometnc DNA analysis was done in all 39 CIN III lesions (CIN and 
CIN INV) and in 20 invasive cancers (INV). 
The results of cytophotometnc analysis of CIN III without adjacent invasive 
carcinoma (CIN), compared with CIN III with adjacent invasive carcinoma 
(CIN INV) are shown in Table 2. 
Table 2 DNA ploidy patterns m cervical intraepithelial neoplasia grade III with and without coexisting 
invasive squamous cell carcinoma* 
CIN CIN INV 
DNA ploidy Total < 35 yr > 50 yr Totdl < 45 yr S 50 yr 
pallcrn 
N N N N N N 
Diploid 2(11%) 2(18%) - 8(40%) 6(60%) 2(20%) 
Polyploid 7 (17%) 6 (55%) 1 (13%) 2 (10%) 1 (10%) 1 (10%) 
Aneuploid 10 (53%) 3 (27%) 7 (88%) 10 (50%) 3 (30%) 7 (70%) 
Total 19 11 8 20 10 10 
'Total and subdivided for two age categories CIN cervical intraepithelial neoplasia grade III 
without adjacent invasive carcinoma, CIN INV CIN III with adjacent invasive carcinoma 
In two cases of CIN the DNA histogram showed a diploid pattern, seven patients 
had a polyploid pattern, and ten an aneuploid pattern DNA analysis in 20 CIN 
Ill-like lesions with adjacent invasive carcinoma (CIN INV) disclosed a diploid 
DNA-pattern m eight cases, a polyploid pattern in two, and aneuploidy in ten 
cases. 
When age of the patients was taken into consideration (Table 2), in CIN III 
lesions (CIN and CIN INV) an aneuploid DNA pattern was most frequently 
found in patients 50 years of age and older, both in the absence (seven of eight 
patients) and in the presence (seven of ten patients) of an adjacent invasive 
squamous cell carcinoma 
In the younger age group (^35 yr) aneuploidy was present in only three of 11 
(27%) patients with CIN III and in three of ten (30%) patients with a CIN.INV 
lesion. A diploid pattern was observed in two (two of 11, 20%) cases of CIN 
lesions in younger patients. In patients with CIN INV lesions, diploidy was found 
50 
Invasive cervical 
cancer (INV) 
Diploid 
Polyploid 
Ancuploid 
Diploid 
8 
-
CIN lll-l.ke lesion 
Polyploid 
-
1 
1 
(CIN INV) 
Aneuplold 
-
1 
9 
in six (60%) younger women and in two (20%) women older than 50 years. A 
polyploid DNA pattern was identified in six (six of 11, 55%) patients from the 
younger age group with a CIN lesion, only in one older patient (one of eight, 
13%) with a CIN lesion and in patients with CIN INV lesions in one patient 
(10%) of each age group 
Table 3 Distribution of DNA patterns m 20 cases of invasive cancer and adjacent cervical intraepithe-
lial neoplasia grade ¡¡¡-like lesions 
Total 
8 
2 
10 
Total 8 2 10 20 
In Table 3 distribution of DNA patterns in 20 invasive squamous cell carcinomas 
(INV) and adjacent CIN lesions (CIN INV) is compared. In 18 of 20 cases (90%) 
DNA patterns in invasive carcinomas were similar to those of adjacent (CIN INV) 
lesions (eight diploid, one polyploid, nine aneuploid). 
In figures ЗА through 3D two characteristic examples are given. In the cases with 
DNA aneuploidy in both the intraepithelial lesion (CIN INV) and the adjacent 
invasive carcinoma, DNA distribution in invasive cancers usually was more scatte­
red. In two cases (10%) DNA patterns of the intraepithelial lesion and the 
invasive cancer were different. In one case the (CIN INV) lesion was polyploid 
whereas the invasive cancer had an aneuploid pattern In the second case (Figs 
4A and 4B) the opposite was noted 
Identification of papilloma virus infection 
Papillomavirus common antigen could be detected in four women younger than 
35 years of age with a (CIN) lesion. Papillomavirus was not detected in any of 
the other lesions.The DNA pattern was polyploid in three of these four younger 
patients In the fourth patient a bimodal aneuploid DNA pattern was seen 
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Figure 3A-3D: Diploid DNA patterns present in both (A, lop left) the CIN Ill-like lesion 
(CIN.INV) and (B, top right) the adjacent invasive cancer (INV) (patient 33 
years of age). (C, bottom left) Polyploid CIN Ill-like lesion (CIN.INV) and 
(D, bottom right) polyploid invasive cancer (INV) (same patient as Figs. 2C 
and 2D). 
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Figure 4А^В: (A, left) Aneuploid DNA pattern of CIN Ill-like lesion (CIN.INV) and (B, 
right) polyploid DNA pattern in invasive cancer (INV) in the same patient 
(patient 62 years of age). 
DISCUSSION 
Cytophotometric and flow cytometric DNA analysis of selected areas of cervical 
intraepithelial neoplasia grade III and invasive squamous cell carcinoma was 
performed using whole nuclei extracted from paraffin-embedded tissue (29-31). 
With this method selected areas of archival paraffin-embedded tissues can be 
analyzed retrospectively. 
Stromal and normal epithelium cells can be removed from the specimen under 
a dissecting microscope, thus reducing the mostly diploid component of benign 
cell populations (29), which may obscure small aneuploid fractions. The selection 
of areas of CIN HI or invasive cancer by elimination of nonrelevant tissue 
segments before nuclear isolation makes DNA histograms truly representative of 
the epithelial lesion under study (29,30). Furthermore, DNA measurements of 
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intact nuclei are more reliable than measurements in nuclei in tissue sections 
(8,11,12,29). 
In this study sufficient material was available in seven cases of invasive cancers 
for both cytophotometric and flow cytometric DNA analysis. The results of both 
measurements were comparable: a high first (diploid) peak in the FCM histograms 
was the result of residual lymphocytes and stromal cells still present in the sample. 
In this study cytophotometric DNA analysis was possible in all cases of CIN III 
and invasive cancer. In 18 of the 20 cases (90%) DNA patterns of CIN Ill-like 
lesions and adjacent invasive squamous cancers were similar, implying that these 
CIN lesions are true precursors of invasive cancer. 
Cytophotometric DNA analysis of both pure CIN III and CIN Ill-like lesions in 
the presence of invasive cancer showed DNA aneuploidy in 51%, polyploidy in 
23%, and diploidy in 26%. These figures differ considerably from data published 
by others (9-11) even when taking into account that these authors were using 
different methods or somewhat different definitions of aneuploidy (Table 4). 
Table 4. Comparison of the current results with data from previous studies by Jakobson et al (10) 
and Fu et al (11). 
Siudy by Fu et al. (11) Jakobsen et al. (10) Current study 
Year 1981 1983 1987 
Material Paraffin-embedded tissue Fresh biopsy Paraffin-embedded tissue: 
14-μιη section nuclei isolated from 
50-μπι sections 
Technique of Microspcctrophotomctry, Flow cytometric analysis Cylophotomelric analysis 
DNA analysis single wavelength, 
plug 
No of patients 100 
No. of CIN III 10 
DNA pattern 
Diploid 0 
Polyploid 0 
Ancuploid 10 
Age of patients Not 
method 
investigated 
121 
47 
10 
-
47 
Not investigated 
39 
39 
10 
9 
20 
21 patients < 35 yr 
18 patients 2 50 yr 
Jakobsen et al. described FCM analysis of fresh cervical biopsy material of 121 
patients. From 47 cases identified as severe dysplasia or carcinoma in situ, 37 
(79%) DNA histograms were aneuploid (10). 
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Fu et al. described the results of microspectrophotometric DNA measurements 
using a single wavelength plug method in 14-дт paraffin sections. In their study 
of 100 patients all ten cases diagnosed as CIN III were aneuploid (11). Nasiell 
et al. (9) used scanning microspectrophotometry for DNA measurements in 
cytologic preparations, defining aneuploidy by the "5-c exceeding rate". In all six 
cases of carcinoma in situ in their study they found a significant aneuploid cell 
fraction 
In none of these studies age distribution of patients was taken into account In 
the current study 78% (N = 14) of CIN III lesions in women 50 years of age or 
older, with as well as without coexisting invasive cancer, were aneuploid In 
contrast the frequency of aneuploidy in CIN III and CIN Ill-like lesions in 
younger women was remarkably low (29%, N = 6). 
These differences in frequency of aneuploidy in the two age groups may indicate 
two biologically different neoplastic processes. In the group of younger women 
a diploid DNA pattern was found in about 60% (N:6) of intraepithelial lesions 
with adjacent invasive cancer (CIN INV). This high percentage is at variance with 
data from others. 
In the study of Fu et al. none of the 10 CIN III lesions was diploid (11). A 
diploid pattern was recorded in CIN I and II lesions only. Diploid and polyploid 
DNA patterns were previously thought to be found almost exclusively in reactive 
processes and in regressive CIN lesions (11,13,36). When Jakobsen et al. noted 
about 20% diploidy in CIN III lesions (10), these authors attributed this observati­
on to the small size of the intraepithelial lesions in their study. However, Spnggs 
et al. using cytogenetic techniques, in specimens of carcinoma in situ, already 
demonstrated the modal chromosome number in 29% of cases to be in the diploid 
range (37). Atkin also stressed that diploid DNA patterns of CIN III lesions did 
not necessarily indicate good prognosis (15). 
Finally, diploid DNA patterns also have been found in cervical invasive cancer 
and in other malignant tumors in a variety of organs such as breast, esophagus, 
stomach, colon, endometrium, head and neck squamous carcinomas, and ovaries 
(13,36). Our data strongly support the fact that a diploid DNA pattern in a CIN 
III lesion does not exclude progression to invasive cancer and is not necessarily 
indicative of a reactive or regressive change. 
The significance of polyploidy in CIN ΠΙ lesions is uncertain. The assumption 
that polyploidy indicates a reactive change is supported by the relatively high 
percentage (55%) of polyploid CIN III lesions in the absence of an invasive 
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carcinoma (CIN) m younger women and the low percentage (10%) in older 
women (13%) in (CIN.INV) lesions (10%), and in invasive cancer (10%). 
In three of the polyploid CIN III lesions without invasive cancer (CIN), HPV 
common antigen was present. This supports an infectious nature of these lesions. 
Further behavior of the polyploid lesions is as yet unknown. 
Based on our analysis of DNA ploidy m cervical intraepithelial neoplasia grade 
III, using nuclei isolated from paraffin-embedded tissue, the conclusion is warran-
ted that a significant proportion of diploid CIN III lesions in younger women have 
invasive potential and thus a diploid DNA pattern in CIN III lesions should not 
automatically be considered to be an indicator of good prognosis. Our findings 
also suggest that processes leading to invasive cancer of the cervix may be 
biologically different in younger and older women. However, the current group 
of 39 patients is too small to draw definitive conclusions. 
Further analysis using a larger group of patients should provide more detailed 
information on the relation between DNA ploidy patterns of CIN III lesions of 
the uterine cervix and their progressive or regressive behavior. 
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DNA PLOIDY AND CYTOPHOTOMETRIC ANALYSIS OF 
CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE III AND 
INVASIVE SQUAMOUS CELL CARCINOMA. 
A.G.J.M. Hanselaar, G.P. Vooijs, M.M.M. Pahlplatz 
Abstract Cervical Intraepithelial Neoplasia grade III (CIN III), and Squamous 
Cell Carcinoma (INV) were examined using DNA ploidy and cytophotometric 
analysis. Based on hysterectomy, exconisation and biopsy material from 69 patients 
in two age categories, analysis was performed in nuclei isolated from selected 
areas of paraffin-embedded tissue. High percentages of DNA-diploidy in INV 
lesions were found mainly in the group of patients, age 45 years or younger. CIN 
III lesions in women, age 46 or older, demonstrated high percentages of DNA-
aneuploidy. DNA-poIyploidy was most frequent in CIN III lesions in the younger 
age category. The results of cytophotometric analysis indicated that the overall 
mean values of 16 nuclear photometric features discriminated significantly between 
the complete groups of CIN III (N = 37) and INV (N = 32). On an individual 
patient level however the mean feature values showed a large overlap. Based on 
the results of a stepwise linear discriminant analysis of patient mean values, a 
combination of geometrical and runlength texture features was used to discriminate 
between CIN III and INV lesions. The correct classification rate was highest in 
the category of patients in the older age category. The results of this study 
indicate age related differences in CIN III and invasive squamous cell carcinoma. 
The results of this study may be of help in assessing cytophotometric features in 
the study of progressive and non-progressive CIN lesions. 
INTRODUCTION 
Cervical Intraepithelial Neoplasia grades I to III (CIN I - III = Dysplasia and 
Carcinoma in situ) are potentially precancerous lesions. They can progress to 
invasive squamous cell carcinoma, but also persist or return to normal. Earlier 
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development of CIN III (= severe dysplasia and carcinoma in situ), at what time 
the patients were treated or left the study. Data on the follow-up of CIN III itself 
are less frequent but generally indicate that a relatively small number of CIN III 
lesions will eventually progress to an invasive squamous cell carcinoma (9,12,13,18, 
19). Light microscopically CIN III can not be subdivided in progressive, persistent 
or regressive subtypes, and as a consequence all cases of CIN III are treated as 
essentially premalignant, potentially progressive lesions. 
An alternative for visual light microscopic evaluation of CIN HI lesions, is the 
study of nuclear DNA ploidy and cytophotometric analysis of structural nuclear 
changes. DNA ploidy analysis, using flow cytometric and histometric techniques, 
have indicated high percentages of DNA-aneuploidy in CIN III lesions (10,16). 
On this basis some authors concluded that DNA-aneuploidy is a marker for 
progression in CIN lesions (10). In a recent study on 39 patients with CIN III, 
with and without synchronous invasive squamous cell carcinoma, we found DNA-
aneuploidy in about 50 % of cases (14). A striking observation in our study was 
the effect of age, dividing the group of patients in two categories: in women 50 
years of age or older, a DNA-aneuploid pattern was present in 88 %, whereas 
in women 35 years of age or younger, a DNA-aneuploid pattern was only present 
in 27 %. In women 35 years or younger DNA-polyploidy was the most frequent 
pattern in CIN III lesions. A DNA-diploid pattern was most often found in CIN 
Ill-like lesions adjacent to invasive squamous cell carcinoma. Our findings sugge­
sted that processes finally progressing to invasive cancer of the cervix are biologi­
cally different between younger and older women. In addition to the studies of 
Atkin, who showed high percentages of DNA-diploidy in cervical invasive cancer, 
we found that a diploid DNA pattern not necessarily implied a regressive or 
persistent behavior of the CIN III lesions (1,2,14). 
Nuclear characteristics of CIN HI and Invasive Squamous cell carcinoma can 
also be studied by cytophotometric analysis. Digitized images offer information 
on nuclear features such as geometry, density and texture, that are not perceived 
on light microscopic evaluation even by well-trained human observers. Cytophoto­
metric analysis was proven to be of value in the study of cervical intermediate 
cells present in "normal", dysplastic and carcinoma in situ specimens, in studies 
of normal and malignant endometrium, in the differential diagnosis in pleural 
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effusions and in the discrimination between classic and variant type small cell lung 
cancer cell lines (5,6,17,23,24). 
In the present study digitized interphase nuclei of CIN III lesions and of cervical 
invasive squamous cell carcinomas were analyzed for DNA ploidy and cytophoto-
metric nuclear features in an effort to characterize the pre-invasive CIN III lesions 
and cervical invasive squamous cell carcinomas by image analysis techniques. 
Furthermore it will be assessed whether the findings can be used for classification 
of lesions in individual patients. 
In order to identify differences between regressive or persistent and progressive 
intraepithelial abnormalities, future analyses will deal with cytophotometric analysis 
of CIN Ill-like lesions bordering invasive squamous cell carcinoma and of CIN 
lesions that showed progression to invasive squamous cell carcinoma (15). 
MATERIAL AND METHODS 
Patient group. 
Paraffin-embedded cervical tissue specimens of 69 patients, treated by hysterecto-
my, exconisation or extensive diathermic biopsy, were studied. In 37 patients the 
histological diagnosis was Cervical Intraepithelial Neoplasia grade III, without evi-
dence of (micro-) invasive squamous cell carcinoma (CIN III). An intraepithelial 
lesion was defined as a CIN III lesion when "undifferentiated" basal or parabasal 
type cells with irregular arrangement, crowding, indistinct cytoplasmic boundaries, 
nuclear enlargement, a high nucleo-cytoplasmic ratio and frequent mitotic figures, 
occupied from two thirds up to the full thickness of the epithelial lining (7). In 
32 patients the histological diagnosis was cervical invasive squamous cell carcinoma 
(INV). These two groups were further subdivided into age categories, 45 years 
of age or younger and 46 years of age or older (Table 1). 
Cell material. 
The specimen preparation procedure, which has been described in detail elsewhe-
re, includes extraction of intact nuclei from selected areas of paraffin-embedded 
tissue (14,21,22). In short, it includes selection of the CIN III, and INV lesions 
from 50 micrometer "thick" paraffin-embedded tissue sections, using a dissecting 
62 
microscope. After incubation with 0.1 % protease of 370C for 60 minutes and 
centrifugation, the cell suspension is placed on slides and stained with a DNA 
specific Thionm-Feulgen stain (23). 
Table 1 Cervical epithelial abnormalities, subdivided into type of lesion and age categories * 
Type of lesion CIN III INV Total 
Number of lesions 37 32 69 
Number of patients 
in two age categories 
S45 yrs 26 15 41 
b46yrs. 11 17 28 
* CIN III = cervical intraepthelial neoplasia grade III INV = invasive squamous cell carcinoma 
Digitization 
Approximately 200 nuclei per specimen were used for cytophotometnc analysis 
Cell images were digitized with an Orthoplan (Leitz Wetzlar, W.-Germany) 
scanning microscope, provided with a linear diode array (Fairchild, USA), which 
was interfaced to a MINC minicomputer with a LSI 11/23 microprocessor (Digital 
Equipment Corp., Manyard, MA). Nuclei were measured with a 40 χ objective 
and monochromatic light at a wavelength of 585 nm (band width 20 nm). The 
sampling density was four pixels per micrometer. Nuclear boundaries were 
automatically determined from the digital image by grey level boundary following. 
As an "internal" standard for DNA-content 20 lymphocytes were measured in each 
of the samples. Twenty-one nuclear features, describing geometrical, density and 
texture characteristics (Table 2) and one sample feature (total DNA content in 
the total sample of nuclei) were extracted from the digitized image (24) DNA 
content of measured nuclei was expressed as DNA-index (D I.), defined as the 
integrated optical density of a nucleus divided by the median integrated optical 
density of the "internal" control lymphocytes (14,22,23). D I distributions were 
estimated by frequency histograms of a sample of nuclei, using a bin-size of 0.1. 
These DNA ploidy patterns were visually classified as DNA-diploid, DNA-polyp-
loid, or DNA-aneuploid, according to the following definitions. In a DNA-diploid 
pattern a distinct G0/G1 peak is found in the (near-)diploid (2C, DI . = 1.0 +/-
10 %) region with a small proportion of cells in S and G2/M (4C) mode, as in 
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normal tissue. In DNA-polyploidy distinct peaks were present in the diploid (2C; 
D.I. = 1.0 +/- 10 %) and tetraploid (4C; D.I. = 2.0 +/- 10 %) regions, or in the 
diploid, tetraploid and octaploid (8C, D.I. = 4.0 +/- 10 %) regions. Ploidy 
patterns were considered DNA-aneuploid in all cases with scattered D.I. distributi-
ons, or uni-, bi-, or multimodal D.I. distributions, that were non-diploid and non-
polyploid 
Table 2 List of photometrical nuclear features 
TEXTURE 
Runlength 
1SRL 
2LRL 
3GLD 
4RLD 
5RPC 
Cooccurrency 
6 HOMOG 
7 CONTR 
8 INVCON 
9 ENTRO 
10 MXTRP 
11 DMOM1 
12 DMOM2 
13 TRISY 
DENSITY 
14 DI 
15 ADI 
16 SODI 
17 M3DI 
GEOMETRY 
18 AREA 
19 CIRC 
20 GMRAT 
21 MASSEC 
Short Runlength Emphasis 
Long Runlength Emphasis 
Grcylevcl Distribution 
Runlength Distribution 
Run Percentage 
Homogeneity 
Contrast 
Inverse Contrast 
Entropy 
Maximum Transition Probability 
First Diagonal Moment 
Second Diagonal Moment 
Triangular Symmetry 
DNA Index 
Average DNA Index 
Standard Deviation of DNA Index 
Third Moment of DNA Index 
2-D Area of the nucleus 
Circularity 
Geomctntal Moments Ratio 
Mass Eccentricity, DNA margination 
Cytophotometnc analysis of 21 nuclear features was performed on a total of 
12562 cell nuclei of 69 lesions. First the mean values of nuclear features m the 
complete groups of CIN III (n = 37) and INV (n = 32) lesions were calculated 
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Thereafter the mean values and standard deviations of the nuclear features in all 
individual patients were calculated and used in a statistical analysis to determine 
the most promising feature for classification purpose. 
Statistical Analysis. 
Statistical analysis on the sets of 21 photometric nuclear features was carried 
out using the Statistical Analysis System package (29), e.g. general linear models 
procedure, stepwise linear discriminant analysis and linear discriminant analysis. 
The general linear models procedure was used to characterize the groups of CIN 
III and INV. A stepwise linear discriminant analysis, using the data from 21 
photometric features obtained from 69 patients subdivided in CIN III and INV 
groups, was used to select the best discriminating parameters and to construct a 
classification criterium for patients with CIN III and INV lesions. This classification 
was performed by linear discriminant analysis. 
RESULTS 
DNA ploidy patient analysis. 
The results of visual interpretation of DNA ploidy patterns of 37 CIN III lesions 
and 32 INV lesions are shown in table 3. A DNA-diploid pattern was found more 
frequent in INV lesions (15 of 32 cases, 47 %) than in CIN III lesions (9/37 cases, 
24%). A DNA-polyploid pattern was found more frequent in CIN III cases (13/37 
cases, 35 %), than in INV lesions (5/32 cases, 16 %) lesions. The frequency of 
DNA-aneuploidy was slightly but not significantly higher in CIN III than in INV 
lesions; 41 % (15/37) in CIN III and 37 % 12/32) in INV lesions. The distribution 
of DNA ploidy patterns in CIN III and INV showed distinct differences between 
the two age categories e.g. patients 45 years of age or younger and patients 46 
years of age or older (table 3). DNA-aneuploidy was found in 23 % of CIN III 
lesions and 20 % of INV lesions in the younger age group, and in 82 % of CIN 
III lesions and in 53 % of INV lesions in the older age group. A DNA-diploid 
pattern was found in the younger age group in 31 % in CIN III lesions and in 
73 % in INV lesions, and in the older age group in 9 % of CIN III cases and 
in 24 % of INV lesions. 
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Table 3 DNA ploidy patterns of CIN III and INV Total and subdivided for two age categories 
DNA ploidy 
paitern 
CIN III 
Diploid 
Polyploid 
Aneuploid 
Total 
N 
9 
13 
15 
% 
24 
35 
41 
< 45 
N 
8 
12 
6 
Vr 
% 
31 
46 
23 
> 46 yr 
N % 
1 9 
1 9 
9 82 
Total 37 100 26 100 11 100 
INV 
Diploid 
Polyploid 
Aneuploid 
Total 
15 
5 
12 
32 
47 
16 
37 
100 
11 
1 
3 
15 
73 
7 
20 
100 
4 
4 
9 
17 
24 
24 
53 
101 
A DNA-polyploid pattern was most frequently found in CIN III lesions in the 
younger age category (46 %) In the older age category in CIN III lesions this 
was 9 %. DNA-polyploidy in INV-lesions was present in 7 % in the younger 
group and in 24 % in the older age category. 
Cytopliotometnc analysis. 
The mean values of the nuclear features in the groups of CIN III and INV are 
shown in table 4. Using the general linear models procedure a significant discrimi-
nation between the groups of CIN III and INV could be made by the group mean 
values of 16 of the 21 nuclear features (SRL, LRL, GLD, RPC, HOMOG, 
CONTR, INVCON, ENTRO, MXTRP, DMOM1, DMOM2, DI, ADI, CIRC, 
GMRAT, and MASSEC). In table 4 highest values of the significantly different 
features are underlined. Group mean values of seven nuclear features (SRL, RPC, 
CONTR, ENTRO, DMOM1, DMOM2, and CIRC) were significantly higher in 
INV than in CIN III lesions. Group mean values of nine other features (LRL, 
GLD, HOMOG, INVCON, MXTRP, DI, ADI, GMRAT, and MASSEC) were 
significantly higher in CIN III than in INV lesions. On individual patient level the 
mean feature values showed a large overlap 
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Table 4 Mean values of nuclear photometric features in CIN ΠΙ and INV lesions The highest 
values of significantly different features, (P < 0 05) are underlined. 
Features 
Texture, runlength 
1 SRL 
2 LRL 
3 GLD 
4 RLD 
5 RPC 
Texture, co-occurcncv 
6 HOMOG 
7 CONTR 
8 INVCON 
9 ENTRO 
10 MXTRP 
11 DMOM1 
12 DMOM2 
13 TRISY 
Densitv 
14 DI 
15 ADI 
16 SODI 
17 M3DI 
Geometrv 
18 AREA 
19 CIRC 
20 GMRAT 
21 MASSEC 
CIN III 
0 277 
97 0 
0185 
0145 
0158 
00457 
1065 
0 699 
1441 
0 0983 
3 304 
0 338 
0103 
1645 
0000909 
0 000346 
0 000690 
1905 
0 770 
2 62 
0 451 
INV 
0300 
87 8 
0.177 
0148 
0169 
0 0438 
1 136 
0688 
1455 
0 0971 
3 420 
0 354 
0101 
1570 
0 000825 
0 000344 
0 000681 
1929 
0 774 
2 38 
0 447 
The results of stepwise linear discriminant analysis, using the mean (M) feature 
values of individual patients, indicated that the most promising parameters for 
discrimination between CIN III and INV were two geometrical and two runlength 
texture features (in order of significance: M-GMRAT, M-SRL, M-MASSEC and 
M-LRL). With these features 78% of the CIN III and INV lesions could be 
classified correctly in individual patients. The results of linear discriminant analysis 
are presented in table 5-A. The false positive rate, defined as the percentage of 
"a prion" CIN III lesions classified as INV, was 22 %. The missed-positive rate, 
defined as the percentage of "a prion" INV lesions classified as CIN III was also 
22 %. 
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8 
25 
33 
6 
9 
15 
1 
16 
17 
22 
78 
48 
23 
60 
37 
9 
94 
61 
37 
32 
69 
26 
15 
41 
Π 
17 
28 
100 
100 
100 
100 
100 
100 
100 
100 
100 
Table 5: Cytophotometric analysis; classification results of discriminant analysis between CIN III 
and INV lesions, based on four features, M-GMRAT, M-SRL, M-MASSEC and M-LRL. (Total 
and in two age categories). 
CIN III INV Total 
N % N % N % 
A: Total groups of CIN III and INV. 
CIN III 29 78 
INV 7 22 
Total 36 52 
B: Lesions in women < 45 years of age. 
CIN III 20 77 
INV 6 40 
Total 26 63 
C: Lesions in women > 46 years of age. 
CIN HI 10 91 
INV 1 6 
Total 11 39 
The morphologic picture that emerges from these analyses is that the nuclei of 
CIN III lesions have a less rounded, more elongated shape, more DNA margina-
tion more coarse and less fine granularity of the chromatin than the nuclei of INV 
cells. When included in a stepwise linear discriminant analysis, numerical age was 
the second most important parameter, next to feature M-GMRAT. This could be 
partly explained by the number of younger patients with CIN III lesions, in this 
study, being more than twice the number of older patients with CIN III lesions. 
A linear discriminant analysis using age as a numerical parameter was therefore 
not performed for the entire series of patients. For each separate age category 
(45 or younger and 46 or older) however a linear discriminant analysis of CIN 
III and INV, was possible. This analysis, based on the features M-GMRAT, M-
SRL, M-MASSEC and M-LRL, showed distinct patterns for the two age catego­
ries, as illustrated in tables 5-B and 5-C. In the youngest age category a correct 
classification of CIN III was made in 77 % (false positive rate of 23 %) and of 
INV in 60 % (false negative rate of 40 %). In the oldest age category, the correct 
classification of CIN ΠΙ was 91 % (false positive rate of 9 %) and the correct 
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Classification of INV was 94 % (false negative rate of 6 %). 
The results of stepwise linear discriminant analysis, including standard deviations 
(S) of the feature values of individual patients demonstrated a slight shift of the 
most significantly discriminating features. The most promising features were M-
GMRAT, M-SRL, S-CONTR and M-LRL. With those features the linear discri-
minant analysis of CIN III and INV, gave similar results as was found using only 
the mean values of the cytophotometric features. The correct classification of the 
complete groups of CIN III and INV were 78% and 75% respectively. In the 
younger age category these percentages were 69% and 68%; in the older age 
category they were 91% and 88% respectively. A Jackknife procedure, performed 
on these data using the latter four features showed a 76% correct classification 
in the complete group of CIN III lesions and 75% correct classification in the 
complete group of INV lesions. 
DISCUSSION 
DNA ploidy pattern analysis of 37 cervical intraepithelial neoplasias grade III 
and 32 invasive squamous cell carcinoma lesions showed that there is not a single 
specific DNA ploidy pattern that can characterize the group of CIN III or INV 
lesions. The present results lent support to earlier findings that DNA-diploidy does 
occur in CIN III and INV lesions and therefore that DNA diploidy does not 
exclude an invasive potential (1,14). This is consistent with the finding that DNA-
diploidy, as measured by DNA ploidy analysis, not automatically means that a 
complete set of 46 normal chromosomes is present in each measured cell. Structu-
ral chromosome changes and small numeric changes will not be discovered by 
DNA ploidy analysis alone. The present study of DNA ploidy patterns of 69 
specimen of CIN III and INV lesions does indicate age related differences. DNA-
diploidy was encountered most often in INV (73 %) lesions in patients, 45 years 
or younger. The highest frequency of DNA-polyploidy was found in CIN III lesions 
in this age category (46 %). DNA-aneuploidy was most frequent in CIN III (82%), 
and INV (53%) lesions in women 46 years of age or older. With increasing age 
DNA ploidy patterns of these lesions tend to be more frequently aneuploid. This 
raised the question whether DNA-aneuploidy is more age related than tumor 
related and whether DNA-aneuploidy could also be found in normal cervical tissue 
of older women. However, in a pilot series of formalin fixed, paraffin-embedded, 
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normal ectocervical epithelium from ten women 46 years of age or older, using 
the same preparation technique as used in the present study, all specimen were 
DNA-diploid. No DNA-aneuploidy was found. 
In a study of DNA ploidy in cervical squamous cell carcinoma, Atkin also noted 
differences in age distribution according to the ploidy group. He described a 
possible tendency for younger patients (up to 40 years) to have near-diploid and 
older patients (over 70) to have near-triploid or near-tetraploid tumors (1). The 
mean age of patients at the time of detection of an invasive squamous cell 
carcinoma of the cervix is around 50 years (48.2-53.4 years) (25,26). The mean 
age of patients with diagnosis of carcinoma in situ is around 40 years (36.6-42.5 
years) (25,26). Recently carcinoma in situ was reported to be diagnosed with an 
increased frequency in women under the age of 35 (11). Furthermore Berkeley 
et al and Prendiville et al reported the occurrence of cervical invasive carcinoma 
in young women after a recent negative cervical cytologic control, indicating that 
cervical cancer in young women may have a very short preinvasive phase (3,27). 
Nasiell et al observed, in a follow-up study of 849 patients with moderate dysplasia 
(CIN II), different progression rates in women over 51 and in younger women 
(20). In women over 51 years of age the progression interval time was significantly 
longer than for women in the age group of 26 to 50 (20). In view of these and 
our present findings we strongly doubt if a new classification of Cervical Intraepi-
thelial Neoplasias should be based exclusively on ploidy patterns, as was suggested 
by Bibbo et al (4). In our study the differences of DNA ploidy patterns between 
CIN III and INV lesions were small, with a relatively high number of lesions in 
some of the age groups demonstrating a DNA diploid pattern. 
Through the use of cytophotometric technique, as performed in this study, CIN 
III lesions and invasive (INV) lesions could be characterized by 16 of 21 nuclear 
features. With the use of mean values of four nuclear features, CIN III and INV 
lesions were correctly classified in 78 % of cases. Some authors state that cytologi-
cal specimens of in situ carcinoma and invasive carcinoma cannot be discriminated 
on a cellular basis alone (25). According to others invasive carcinoma can be dis-
criminated from carcinoma in situ by the presence or absence of macronucleoli 
in the nuclei in invasive carcinoma (25). Our present findings of the significance 
of Mass Eccentricity of the nuclear chromatin in the discrimination of CIN III and 
INV are consistent with earlier cytologic finding of better defined nuclear membra-
nes in carcinoma in situ, when compared with invasive carcinoma. In the present 
study the shape in CIN III nuclei was found to be more elongated and less round, 
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based on features GMRAT and CIRC This is not completely consistent with 
findings of Patten, who described a slightly higher frequency of rounded nuclei 
in carcinoma in situ (25). Our finding of the discriminating power of Short and 
Long Runlength Emphasis correspond with the light microscopic observation of 
a more coarse granular chromatin pattern in carcinoma in situ when compared 
with invasive carcinoma (25). As could be expected the mean area of CIN III 
nuclei was lower than that of INV lesions, however not significantly so, because 
of considerable overlap between patients. 
Our finding of the discriminating power of cytophotometric chromatin texture 
and geometrical nuclear features, correlate with previous findings in cervical 
intermediate cells, normal and malignant endometrium, lymphocytes, pleural 
smears and small cell lung cancer cell lines (4,5,6,17,23,24). The significance of 
the subdivision in two age categories was illustrated by the effect of age on the 
correct classification rate of CIN III and INV, being 77 % and 60 % respectively 
in the youngest age category and 91 % and 94 % in the oldest age category. The 
cytophotometric and DNA ploidy analyses in this study indicate that age could 
be an important parameter in the study of nuclear DNA content and distribution. 
These differences may be explained by different underlying biological processes, 
related to CIN III lesions and invasive squamous cell carcinomas in younger and 
in older women. There may be the effect of different etiological moments (like 
repeated viral infections), but it may also be an effect of different types of tissue 
reaction in the cervix uteri in patients in these age categories. 
Based on the results of the present study, it may be concluded that cytophotome-
tric analysis distinguishes between CIN III and INV lesions in nuclei retrieved 
from paraffin embedded lesions. Furthermore cytophotometric analysis proved to 
be a better technique for discrimination between CIN III lesions and INV lesions, 
than DNA ploidy analysis. Whether cytophotometric analysis can be of value in 
discriminating between progressive and regressive CIN lesions, needs to be further 
evaluated. The present results will be used as a model system for a future analysis 
of Cervical Intraepithelial Neoplasia grade III - like lesions related to synchronous 
invasive squamous cell carcinoma and of CIN I, II and III lesions in patients. 
which after a long interval period, showed progression to invasive squamous cell 
carcinoma. 
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CYTOPHOTOMETRIC ANALYSIS OF 
CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE III, 
WITH AND WITHOUT SYNCHRONOUS 
INVASIVE SQUAMOUS CELL CARCINOMA 
A.G.J.M. Hanselaar, G.P. Vooijs, 
A.E. van 't Hof-Grootenboer, M.M.M Pahlplatz 
Abstract Cytophotometric analysis was performed in nuclei retrieved from 
paraffin-embedded cervical tissue from 57 cases of CIN III. CIN III lesions of 
patients without invasive squamous cell carcinoma (N=37), were regarded to 
represent a mixture of progressive and non-progressive lesions. The CIN III lesions 
of patients with a synchronous invasive squamous cell carcinoma (N=20), were 
regarded as representing truly progressive precursor lesions (CIN.INV). Twenty-
one photometric features describing geometrical, density and texture characteristics 
were extracted from the digitized nuclear images. Statistical analysis of cytophoto-
metric data indicated significant differences between the group of CIN III lesions 
and CIN.INV lesions. A cluster analysis, using one co-occurrency texture feature 
(S-HOMOG), one density feature (S-DI) and two geometrical features (S-AREA 
and M-CIRC), showed that two clusters (CI and C2) were present in the total 
group of CIN III and CIN.INV lesions. The vast majority of CIN.INV lesions was 
member of one and the same cluster CI. The CIN III group appeared to consist 
of a mixture of two clusters, 54% CI and 46% C2 lesions. Of patients 45 years 
or younger, the majority (62%) of CIN III lesions had feature values, correspon-
ding with those of cluster CI, and as such possibly with a potentially progressive 
course. In patients older than 45 years the percentage of CIN III lesions with CI 
feature values was 27%. 
INTRODUCTION 
Patients with Cervical Intraepithelial Neoplastic (CIN) lesions are more and more 
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treated in an early stage of disease by destructive surgical methods such as 
diathermic ablatio, laserevaporisation, cryocoagulation, exconisation or even 
hysterectomy. Although cervical intraepithelial neoplasia lesions may progress to 
invasive cancer, a significant part would not have a progressive course when left 
untreated (6,12,13,16,22). The precise frequency of progression of CIN into 
invasive squamous cell carcinoma is not known. 
It is not possible to predict by visual lightmicroscopic observations alone, what 
CIN lesions will have a progressive or a non-progressive course. Therefore light 
microscopically detected CIN I - III lesions must be regarded as a mixture of 
potentially progressive, persistent and regressive lesions. A logical approach to the 
study of progressive CIN lesions is to study those CIN III lesions, that are found 
adjacent to invasive squamous cell carcinoma. The study of CIN III lesions 
adjacent to invasive carcinomas is not new; it was already in 1910 that Rubin 
speculated that the epithelial abnormalities adjacent to invasive carcinomas were 
the preinvasive stages of cancer (25). CIN III lesions that are adjacent to invasive 
carcinoma (CIN.INV) cannot be discriminated from CIN III lesions without 
adjacent invasive cancer (CIN III), by lightmicroscopical inspection. 
An alternative approach for the lightmicroscopical evaluation of CIN III lesions, 
is cytophotometric analysis of nuclei, stained with a DNA specific stain (1,3,9,11). 
Measurement of texture, density and geometry of digitized nuclei is objective and 
allows statistical analysis. In a recent cytophotometric study of nuclei isolated from 
paraffin-embedded tissue we indicated the importance of this technique in discrimi-
nating between CIN III and invasive squamous cell carcinoma (9). It was possible 
to differentiate between nuclei derived from CIN III lesions and nuclei from 
invasive squamous cell carcinoma (INV) by the group mean values of 16 nuclear 
features and to classify individual lesions correctly in 78% of cases by the patient 
mean values of two geometrical and two texture features. The results of classifica-
tion varied in two age categories. The correct classification rates were lowest in 
the group of women 45 years of age or younger (77% correct classification in CIN 
III and 60% in INV) and highest in the group of women 46 years of age or older 
(91% correct classification in CIN III and 94% in INV). 
In the present study a cytophotometric analysis of texture, density and geometrical 
features was performed in digitized interphase nuclei from CIN.INV and CIN III 
lesions. The premalignant potential of CIN III lesions without concomitant invasive 
squamous cell carcinoma was regarded as "unknown", which implies that in this 
group of lesions potentially progressive and non-progressive lesions were thought 
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to be present. CIN.INV lesions with synchronous invasive squamous cell carcinoma 
were regarded to represent truly progressive precursor lesions (8). 
The aim of the study was to find features discriminating between progressive 
and regressive or persistent CIN III lesions. 
MATERIAL AND METHODS 
Patient groups. 
Paraffin-embedded cervical tissue derived from hysterectomy or exconisation 
specimens and from biopsy material of 57 patients was studied. In 37 patients 
the histological diagnosis was Cervical Intraepithelial Neoplasia grade III, without 
concomitant invasive squamous cell carcinoma (CIN III) (Table 1). 
Table 1: Cervical intraepithelial abnormalities, subdivided by type of lesion and age categories. 
Type of lesion 
Patients 
<= 45 yrs. 
> 45 yrs. 
*) 
CIN IH 
26 
11 
CIN.INV 
10 
10 
To 
36 
21 
Total 37 20 57 
* CIN III = Cervical Intraepihelial Neoplasia Grade HI. CIN.INV = Cervical Intraepthelial 
Neoplasia Grade III, adjacent to Invasive Squamous Cell Carcinoma. 
In 20 patients the histological diagnosis was Cervical Intraepithelial Neoplasia 
grade III with concomitant cervical invasive squamous cell carcinoma (denoted 
as CIN.INV and INV respectively). An intraepithelial lesion was defined as CIN 
III or CIN.INV, when "undifferentiated" basal or parabasal type cells, with nuclear 
enlargement, indistinct cell boundaries, a high nucleo-cytoplasmic ratio and 
frequent mitotic figures occupied from two thirds up to the full thickness of the 
epithelial lining (5). These two groups of patients were further subdivided into 
two age categories; 45 years of age or younger (N = 36) and older than 45 years 
of age (N = 21) (9). 
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Cell material. 
The specimen preparation procedure included selection of CIN III, CIN.INV and 
INV areas in 50 micrometer, "thick" paraffin-embedded tissue sections, using a 
dissecting microscope (8,17,18). After incubation with 0.1% protease of 37 С for 
60 minutes and centrifugation, the cell-nuclei were transferred to slides and stained 
with the DNA specific Thionin-Feulgen stain (19). 
Measurements 
Per specimen about 200 nuclei were digitized using an Orthoplan (Leitz Wetzlar, 
W.-Germany) scanning microscope, provided with a linear diode array camera 
(Fairchild, USA), which was interfaced to a MINC minicomputer with a LSI 11/23 
microprocessor (Digital Equipment Corp., Manyard, MA). Nuclei were measured 
with a 40 χ objective and monochromatic light at a wavelength of 585 nm (band 
width 20 nm). The sampling density was four pixels per micrometer. Nuclear 
boundaries were automatically determined from the digital image by grey level 
boundary following. Twenty-one nuclear features, describing geometrical, density 
and texture characteristics were extracted from the digitized image (table 2) 
(7,8,10,20,21,24). As an internal standard for DNA-content 20 lymphocytes were 
measured in each of the samples. Mean (M) and standard deviation (S) values 
of the 21 nuclear photometrical features were calculated for each lesion. 
Statistical Analysis 
The aim of the study was to determine if the group of CIN III lesions could be 
subdivided into two subgroups: 1) a group of lesions with similar feature values 
to the group of CIN.INV lesions and as such possibly representing potentially 
progressive lesions, 2) a group of lesions with feature values dissimilar to the 
CIN.INV lesions. For this purpose features were selected that could discriminate 
between CIN III and CIN.INV lesions, assuming these to be good candidates for 
discrimination of the two subgroups. Depending on the distribution of the features 
a t-test or Mann-Whitney U-test were used to select features discriminating 
between the groups of CIN III and CIN.INV. 
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Table 2 List of photometncal nuclear features. 
TEXTURE 
Runlength 
1:SRL 
2:LRL 
3:GLD 
4RLD 
5RPC 
Cooccurreney 
6 HOMOG 
7.CONTR 
8INVCON 
9 ENTRO 
10 MXTRP 
11 DMOM1 
12 DMOM2 
13 TRISY 
DENSITY 
14 DI 
15:ADI 
16 SDDI 
17 M3DI 
GEOMETRY 
18 AREA 
19 CIRC 
20 GMRAT 
21 MASSEC 
Short Runlength Emphasis 
Long Runlength Emphasis 
Greylevel Distribution 
Runlength Distribution 
Run Percentage 
Homogeneity 
Contrast 
Inverse Contrast 
Entropy 
Maximum Transition Probability 
First Diagonal Moment 
Second Diagonal Moment 
Triangular Symmetry 
DNA Index 
Average DNA Index 
Standard Deviation of DNA Index 
Third Moment of DNA Index 
2-D Area of the nucleus 
Circularity 
Geometrical Moments Ratio 
Mass Eccentricity; DNA margination 
A stepwise linear discriminant analysis was performed, based on all 42 M and S 
feature values (after an adequate transformation to "normality") of individual 
patients. All selection procedures were performed in the complete groups of CIN 
III and CIN.INV lesions and in lesions of women in two age categories, viz. <=45 
years of age and > 45 years. 
Ward's cluster analysis was carried out within the total group of lesions, using 
the best discriminating M and S features from the t-test, Mann Whitney U-test 
and stepwise discriminant procedures (26,27). The Ward procedure implies the 
use of standard deviation-scores of the features. The clustering procedure aimed 
to reach a division of the CIN III group under the condition that the CIN.INV 
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group was not splitted up. In this manner CIN III lesions could be identified, that 
had corresponding feature values to the CIN.INV group. Due to the small 
numbers of observations, the results of the procedures for feature selection and 
cluster analysis must be regarded as explorative. 
RESULTS 
Selection of features in CIN III and CIN.INV lesions. 
To select features for the cluster analysis a t-test or Mann-Whitney U-test and 
a stepwise discriminant analysis were performed. Using the t-test a significant 
difference (p<0.05) between the complete groups of CIN III and CIN.INV was 
found for the mean and standard deviation of DNA Index (M-DI,S-DI) and for 
the standard deviation of Area (S-AREA). In the older age group significant 
differences between CIN III and CIN.INV were found for the standard deviation 
of one texture feature (S-HOMOG), the standard deviation values of three density 
features (S-DI, S-ADI, S-SDDI) and the standard deviation and mean of two 
geometrical features (M-CIRC and S-AREA). In the younger age group the mean 
value of circularity (M-CIRC) was the only parameter that differed significantly 
between CIN III and CIN.INV. 
The stepwise discriminant analysis (p-entry <0.05) of the complete groups of 
CIN III and CIN.INV, using the mean and standard deviation feature values of 
individual patients yielded one discriminative feature; S-DI. In a stepwise dis-
criminant analysis in patients <= 45 years of age, the most promising features 
were S-DI and M-CIRC. The stepwise discriminant analysis performed in the 
group of patients older than 45 years identified as the most promising features 
S-HOMOG, M-AREA and S-LRL. The feature S-DI, that was initially selected 
as the most promising feature, was discarded during the procedure and replaced 
by S-LRL. 
Cluster analysis of CIN III and CIN.INV. 
As variables in the cluster analysis those features were chosen, that were selected 
twice or more during the above mentioned procedures for the discrimination 
between CIN III and CIN.INV. These variables included the standard deviation 
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of one texture feature (S-HOMOG), the standard deviation of one density feature 
(S-DI), the standard deviation (S-AREA) and mean value (M-CIRC) of two 
geometrical features. 
The results of the cluster analysis are presented in table 3. 
Table 3: Cluster analysis of CIN ΠΙ and CIN.INV, based on S-HOMOG, S-DI, S-AREA and M-
C1RC. A: complete groups of patients, B: patients < = 45 years, C: patients > 45 years. 
A: Complete groups of CIN III and CIN.INV. 
Cluster 1 
CIN III 20 (54%) 
CIN.INV 18 (90%) 
B: CIN III and CIN.INV in patients < = 45 years. 
Cluster 1 
CIN III 16 (62%) 
CIN.INV 10 (100%) 
C: CIN III and CIN.INV in patients > 45 ^ears. 
Cluster 1 
CIN III 3 (27%) 
CIN.INV 8 (80%) 
Cluster 2 
17 (46%) 
2 (10%) 
Cluster 2 
10 (38%) 
-
Cluster 2 
8 (73%) 
2 (20%) 
Total 
37 (100%) 
20 (100%) 
Total 
26 (100%) 
10 (100%) 
Total 
11 (100%) 
10 (100%) 
First the total groups, irrespective of age were analyzed (Table 3-A). The vast 
majority (90%) of CIN.INV lesions appeared to belong to the same cluster 
(cluster 1). According to our hypothesis this cluster would consist of the 'potentially 
progressive lesions. Two cases of the CIN.INV lesions were found in cluster 2. 
About half of the CIN III lesions (20 cases, 54%) were member of the same 
cluster 1. The remaining CIN III lesions (17 cases, 46%) were found to make up 
the second cluster. 
In table 3-B the clustering results for the younger age "category are represented. 
All of the CIN.INV lesions of patients in the age category < = 45 years, were 
a member of cluster 1. In this age group, the number of CIN III lesions belonging 
to cluster 1, was higher (16 cases, 62%) than the number of CIN III belonging 
to cluster 2 (10 cases, 38%). 
In table 3-C the clustering results for the older age category are represented. 
Eight of the CIN.INV lesions were a member of cluster 1 (80%). The two 
CIN.INV lesions that were a member of cluster 2 in the cluster analysis of the 
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complete groups, also belonged to the second cluster of the cluster analysis in 
this specific age group. In one of these cases the CIN.INV lesion was located 
at an uncommonly large distance from the invasive cancer region. Therefore it 
was possible that this lesion that was introduced as a CIN.INV lesion, m fact 
was a synchronous CIN HI lesion of non-progressive potential. The second case 
showed a relatively high S-HOMOG value. Further analysis of this case showed 
a very low mean and standard deviation of integrated optical density of the 
cytospin specimen. This may have influenced the texture measurements, due to 
noise enhancement by equalization of "flat" (non-textured) nuclei (21). The results 
of cluster analysis of CIN III lesions in the older age group demonstrated a lower 
number of lesions belonging to cluster 1 (3 cases, 27%), than to cluster 2 (8 cases, 
73%). 
The distribution over the clusters in the complete groups was consistent with 
the results of cluster analysis as was performed separately in the two age groups. 
Only one CIN III lesion was reassigned from cluster 1 to cluster 2 as a result of 
these repeated cluster analysis within the subgroups. 
In table 4 the means of the clustering variables of the detected clusters are 
presented. This table indicates the differences of the four cluster variables between 
the clusters 1 and 2. The feature values of cluster 1 were lower for S-HOMOG, 
S-DI, S-AREA and higher for M-CIRC. 
Table 4 Cluster means (M) and standard deviations (S) of features used in the cluster analysis 
S-HOMOG 
S-DI 
S-AREA 
M-CIRC 
Cluster 1 
M 
00055 
0 491 
526 
0 774 
fN = m 
S 
00006 
019 
170 
003 
Cluster 2 (Ь 
M 
00068 
0 844 
866 
0752 
I = 19) 
S 
00008 
0 13 
170 
002 
The morphological translation of these findings is that cluster 1 lesions have less 
variation in nuclear DNA-distnbution, DNA-content and nuclear size, and have, 
on the average, more round nuclei. 
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Comparison with synchronous INV lesions. 
In 17 CIN.INV lesions sufficient material of the synchronous invasive squamous 
cell carcinoma lesions was present for cytophotometric analysis. To compare these 
INV lesions with the cluster 1 and cluster 2 lesions, they were classified using a 
discriminant function as obtained by linear discriminant analysis of the clusters 
I and 2, based on the features (S-HOMOG, S-DI, S-AREA and M-CIRC) that 
were used for the cluster analysis. 
The results demonstrated that 13 INV lesions (76%) had feature values similar 
to cluster 1 and four lesions had values similar to cluster 2 (24%). It was thought 
that INV lesions would have had cluster 1 feature values, representing a possibly 
progressive potential. The presence of four INV lesions with values corresponding 
with cluster 2, indicated that the cluster analysis of CIN III and CIN.INV was not 
completely applicable for INV lesions. As a tentative explanation it was considered 
that the final proces of infiltration that discriminates between CIN.INV and INV 
may involve other nuclear changes, than those that were described by the four 
features (S-HOMOG, S-DI, S-AREA and M-CIRC) used in the cluster analysis 
of CIN III and CIN.INV. A stepwise discriminant analysis performed on the 
complete groups of CIN.INV and INV lesions rendered a completely different 
group of 7 significant features. The four most promising features (M-GMRAT, 
M-SRL, S-GLD and M-GLD) gave a correct classification of CIN.INV in 14 of 
20 cases (70%). The correct classification of the 17 cases of INV lesions was one 
hundred percent. 
DISCUSSION 
Earlier cytophotometric studies of CIN lesions concentrated mostly on features 
that could discriminate between, 1) normal and abnormal cell specimen, 2) CIN 
II specimen and CIN III or invasive carcinoma specimen, 3) intermediate cells 
of "normal" cytological specimen and normal appearing intermediate cells in 
cytological specimen with concomitant dysplastic cells (3,4,9,11,14,15,28,29,30,31). 
Wheeler and coworkers were able to correctly classify cells from CIN II, CIN III 
and Invasive carcinoma lesions in about 90% of cases, using cellular and nuclear 
geometrical, density and texture features (30). Recently a karyometric analysis of 
formalin fixed, paraffin-embedded 6 micrometer tissue sections, representing 
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cervical carcinoma in situ and adjacent normal ectocervical mucosa of five pa-
tients, was presented by Montag et al. They showed differences in nuclear shape 
and chromatin distribution of the normal appearing cervical mucosa, depending 
on the distance to the CIS area (15). Bibbo and coworkers presented a related 
study of 6 micrometer sections of four patients with cervical invasive carcinoma 
with adjacent normal appearing epithelium and five control patients. Among others 
the most important parameters for discriminating purposes were the roundness 
of the nucleus, the nuclear perimeter, total optical density and runlength texture 
measure. We were not able to find earlier reports of cytophotometric analyses 
of CIN III and CIN.INV lesions. Our present study of 57 patients showed that 
nuclei from CIN III and CIN.INV lesions yielded cytophotometric information 
that possibly could be of use for the discrimination between progressive and 
non-progressive CIN lesions. Using a cluster analysis, based on one co-occurrency 
texture feature (S-HOMOG), one density feature (S-DI) and two geometrical 
features (S-AREA and M-CIRC), we showed that the vast majority of CIN.INV 
lesions were part of one cluster. If indeed CIN.INV lesions are truly progressive 
precursor lesions as we have assumed, these findings could possibly indicate that 
lesions with "cluster 1" feature values may have the potential to progress into 
invasive lesions. 
As a result of the cluster analysis in this study 20 CIN III lesions (54%) were 
classified as member of "cluster 1", and as such had photometrical characteristics 
similar to the vast majority of the CIN.INV lesions. It was of interest to observe 
that in women 45 years or younger, 62% of the CIN III lesions were classified 
as cluster 1 lesions, and in the group of patients older than 45 years this percenta-
ge was only 27%. These findings might possibly indicate that elderly women have 
less frequently potentially progressive CIN III lesions. The present results are 
difficult to compare with previous studies, since generally accepted rates of 
progression or non-progression of CIN III lesions are still not known (12,13,22). 
The present findings of a possibly more aggressive potential of CIN III lesions 
in younger women link up to earlier findings of Berkeley et al and Prendiville et 
al, who reported fast growing cervical invasive carcinomas in young women after 
recent negative cervical cytological controls (2,23). Furthermore in a follow-up 
study of 849 women with moderate dysplasia (CIN II), Nassiell et al observed that 
CIN II lesions in women over 51 years of age had a significantly longer progressi-
on interval time than women in the age group of 26 to 50 (16). 
Four of the 17 synchronous invasive carcinoma lesions did not have similar 
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feature values as cluster 1. One may speculate that this celbiologically could be 
explained by assuming that in the final proces of infiltration, that discriminates 
between CIN.INV and INV, other nuclear DNA-related changes occur. In that 
respect it was noteworthy that a linear discrimination analysis of CIN.INV and 
INV rendered a 100% correct classification of INV, when four other features were 
used. It is of interest that the major discriminative features M-GMRAT and M-
SRL were also the most discriminative features in our previous study of CIN III 
and INV lesions (9). 
Based on the present study it is concluded that: 1) cytophotometric analysis of 
nuclei, retrieved from paraffin-embedded CIN III and CIN.INV lesions is possible, 
2) in the group of CIN III lesions a subgroup of lesions was present that had 
similar photometric feature values as the vast majority of CIN.INV lesions, which 
as such could eventually indicate a progressive potential, 3) the majority of CIN 
III lesions in younger women had similar feature values as the vast majority of 
CIN.INV lesions. Further analysis of independent data is necessary to validate the 
findings of this study. The present findings are actually being used as a model 
system for an analysis of cytologically detected CIN lesions in patients who after 
a long interval period showed progression to invasive squamous cell carcinoma. 
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CYTOPHOTOMETRIC ANALYSIS OF CORRESPONDING 
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J.H. Gemmink, H. de Leeuw, M.M.M. Pahlplatz 
Abstract Cytophotometric analysis of Cervical Intraepithelial Neoplasia grade 
III (CIN III) was performed in 22 cytological smears (CS) and 22 corresponding 
cytospin specimen, retrieved from selected areas of paraffin-embedded tissues 
(PEC). The average time interval between cytological and histological diagnosis 
was six weeks. CIN III nuclei in CS and PEC specimen were Thionin-Feuigen 
stained and digitized. Beside the visual classification of DNA ploidy patterns also 
the 2.5c and 5c exceeding rates and the specimen mean and standard deviation 
values of 21 photometric features were analyzed. It was shown that there was a 
significant correlation between DNA ploidy patterns in corresponding PEC and 
CS specimen. The 2.5c and 5c exceeding rates were however significantly higher 
in the CS specimen. High resolution cytophotometric analysis of cell nuclei in CS 
and PEC specimen showed significant differences for a large number of nuclear 
photometric features. These findings can possibly be explained by differences in 
selection of CIN III cells from CS and PEC specimen and by differences between 
fixation procedures as used for the two techniques. It was concluded that cytopho-
tometric data of CS and PEC specimen representing CIN III lesions should not 
be regarded as interchangeable among each other. 
INTRODUCTION 
In surgical pathology quantitative morphological analysis of nuclei stained with 
a DNA specific stoichiometric stain may be valuable for diagnostic purposes and 
in predicting the biological behavior of malignant and premalignant lesions. For 
an optimal result of cytometrical analysis, accurate tissue-sampling is essential. 
Many sampling and preparation methods have been described, including several 
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techniques for enzymatical isolation of cell nuclei from fresh or formalin fixed 
paraffin-embedded tissue (7,8,13,17,21,27,28). Further techniques were developed 
for measurements in 4 or 12 micrometer thick paraffin tissue sections, cytological 
imprints, direct cytological smears, fine needle aspirates and monolayers (3,5,6,10, 
13,29). Quantitative analysis of similar lesions using different sampling and prepa-
ration techniques may give conflicting results as was shown by an earlier study 
of 37 breast tumors by Auer et al (3). They demonstrated a weak correlation be-
tween DNA ploidy patterns as obtained from three techniques: microspectro-
photometric analysis of fine needle aspirates, slide cytophotometric analysis of 4 
micrometer tissue sections and flow cytometric analysis of suspensions. 
Recently we presented the results of a cytophotometric study, demonstrating that 
CIN III lesions could be subdivided in two subgroups, possibly indicating progressi-
ve and non-progressive lesions (15). These data were established by an analysis 
of nuclei isolated from paraffin-embedded cervical tissues. It is not known whether 
these cytophotometric findings can be applied to cytological cervical smears. 
In the present study of a group of 22 patients cytophotometric analysis, including 
DNA ploidy pattern analysis, 2.5c and 5c exceeding rate analysis and high resoluti-
on cytophotometric analysis, was performed in routinely prepared cytological 
smears and in cytospin specimen retrieved from selected areas of paraffin-embed-
ded histological material, both representing CIN III lesions. The aim of the study 
was to elucidate the consequences of these analysis in CIN III lesions of the same 
patients using these two preparation techniques. 
MATERIAL AND METHODS 
Patient group. 
A group of 22 women with a cytological and histological diagnosis of Cervical 
Intraepithelial Neoplasia grade III, was studied. The patients, who were treated 
for CIN III at the University Hospital Nijmegen, were selected because of a 
relatively short time interval between the cytological and histological diagnosis. The 
average interval period was 6 weeks, the range was 0 to 19 weeks. 
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Digitization. 
Nuclei of routinely prepared cytological cervical smears (CS) and paraffin-embed­
ded tissue derived cytospin (PEC) specimen were measured through a 40 χ 
objective using the Nijmegen Image Analysis System (NIAS). The NIAS system 
is composed of an Orthoplan (Leitz Wetzlar, W.-Germany) scanning microscope, 
provided with a linear diode array (Fairchild, USA), which was interfaced to a 
MINC minicomputer with a LSI 11/23 microprocessor (Digital Equipment Corp., 
Manyard, MA). Thionin-Feulgen stained nuclei were measured with monochroma­
tic light at a wavelength of 585 nm (band width 20 nm). The sampling density 
was four pixels per micrometer. Nuclei were automatically located in the digital 
images by grey level boundary following. 
Cytophotometric analysis. 
Twenty-one nuclear features, describing geometry, density and texture, were 
extracted from the digitized image (11,16,23,24,25). The nuclear features are 
listed in table 1. The DNA content of nuclei was expressed as DNA-index (DI), 
defined as the integrated optical density of a nucleus divided by the median value 
of integrated optical densities of the internal control nuclei. For each specimen 
mean and standard deviation of the basic nuclear features were calculated to serve 
as specimen features. 
Cytological material. 
The cytological smears were routinely prepared according to the following proto­
col. Superficial cells were scraped off from the surface of the uterine cervix, using 
a wooden spatula with a pointed end, immediately put on slides and fixed with 
a mixture of isopropanol, acetone, poly-oxyethylene and methylene blue (Pro-
Fixx, Lerner Laboratories, Pittsburgh, PA, USA). For routine diagnostic purposes 
the slides were stained according to the Papanicolaou technique, using a CytoTek-
TissueTek II slide stainer (Miles Nederland b.v., Weesp, NL). The cytological 
diagnosis was based on the presence of single and/or clusters of atypical cells 
that were regarded as diagnostic for CIN III lesions. As a consequence of the 
sampling technique with a spatula, the majority of diagnostic cells came from the 
superficial layers of the CIN III epithelium. 
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Table 1: List of photometrical nuclear features. 
TEXTURE 
Runlenglh 
1:SRL 
2:LRL 
3:GLD 
4:RLD 
5:RPC 
Cooccurrency 
6:HOMOG 
7:CONTR 
8:INVCON 
9:ENTRO 
10:MXTRP 
ll:DMOMl 
12:DMOM2 
13:TRISY 
DENSITY 
14:DI 
15:ADI 
16:SDDI 
17:M3DI 
GEOMETRY 
18:AREA 
19:CIRC 
20:GMRAT 
21:MASSEC 
Short Runlenglh Emphasis 
Long Runlength Emphasis 
Grcylcvcl Distribution 
Runlenglh Distribution 
Run Percentage 
Homogeneity 
Contrast 
Inverse Contrast 
Entropy 
Maximum Transition Probability 
First Diagonal Moment 
Second Diagonal Moment 
Triangular Symmetry 
DNA Index 
Average DNA Index 
Standard Deviation of DNA Index 
Third Moment of DNA Index 
2-D Area of the nucleus 
Circularity 
Geometrical Moments Ratio 
Mass Eccentricity; DNA margination 
CIN III cells originating from basal and intermediate layers of the epithelium were 
thought to be rarely present. Normal superficial and some intermediate cells and 
inflammatory cells were in general also present in these slides. 
For cytophotometric analysis the coverslips of the slides were removed using 
xylol and rehydrated according to the following sequence, ethanol 96% (twice), 
ethanol 70%, ethanol 40% and distilled water. Thereafter the specimen were 
fixed in a mixture of methanol, 37% formaldehyde and acetic acid (85-10-5 by 
volume) for one hour, rehydrated, treated with acid hydrolysis (5 N HCL) at 
22° С for 60 minutes and stained with the Thionin-Feulgen stain. No cytoplas­
mic counterstain was performed. An example of a resulting cytological specimen 
is shown in figure 1. 
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Figure 1: A detail of a cylological smear specimen (CS) representing CIN III cell nuclei 
(Thionin-Feulgen stain, magnification: 230x). 
A mean number of 153 diagnostic CIN III cells (range 54-214) per specimen was 
selected for measurements. As an internal control sample in each specimen 20 
cervical intermediate cells were selected. The median values of the integrated 
optical densities (MD.IOD) of the 22 samples of intermediate cells ranged from 
140.9 to 218.4 (mean: 170.7). The mean value of the coefficients of variation of 
the samples was 9.5%. Together with the intermediate cells also 20 granulocytes 
were measured. The MD.IOD values of the 22 samples of granulocytes ranged 
from 125.5 to 182.5 (mean: 149.7). The mean value of the coefficients of variation 
of the samples was 8.7%. Regression analysis of MD.IOD values of the inter­
mediate cell nuclei (lODi) and the granulocyte nuclei (lODg) showed the follo­
wing relation: lODg = 0.87 χ lODi. 
Paraffin-embedded histological material. 
The tissue samples were processed routinely, which included overnight fixation 
in buffered formalin 4% and embedding in paraffin. Thereafter 50 micrometer 
tissue sections were cut, deparaffinized in xylene and rehydrated in graded 
alcohols to distilled water. CIN III areas were selected in the 50 micrometer 
tissue sections, using a scalpel under a dissecting microscope (14,21). The selected 
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CIN III areas were then incubated with 0.1% protease of 37° С for 60 minutes. 
Incubation was terminated by adding 4-5 ml cold phosphate buffered saline (PBS), 
after which the tubes with the CIN III fragments were put into ice. The nuclei 
were washed twice in PBS and centrifuged. The cell suspension in fetal calf serum 
was transported on a slide with a cytocentrifuge apparatus (Shandon, U.K., 10 
min. χ 500 rpm). The slides were briefly air dried and fixed for Ih in a mixture 
of methanol, 37% formaldehyde and acetic acid (85-10-5 by volume). Nuclei were 
than treated with acid hydrolysis (5 N HCL) at 22° С for 60 minutes and stained 
with the Thionin-Feulgen stain. The resulting cytospin specimen, of which an 
example is shown in figure 2, contained cell-nuclei from the superficial, intermedia­
te and basal layers of the CIN III epithelium. 
räP* 
' < % 
»ÌW 
Figure 2: An example of a cytospin specimen (PEC) representing CIN III cell nuclei (Thionin-
Feulgen stain, magnification: 230x). 
A mean number of 173 nuclei (range: 66-200) were randomly chosen per speci-
men and used for cytophotometric analysis. As an internal control 20 lymphocytes 
were selected from the PEC specimen. The median values of the integrated 
optical densities (MD.IOD) of the 22 samples of the lymphocytes ranged from 
76.8 to 186.8 (mean: 117.3). The mean of the coefficients of variation of the 
samples was 8.1%. 
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Interpretation of DNA histograms. 
The DNA histograms were displayed using a bin-size of 0.1. The DNA ploidy 
patterns of cytological and histological cytospin specimen were visually classified 
as DNA-diploid, DNA-polyploid, or DNA-aneuploid, according to the following 
definitions (2,14,15,18). In a diploid pattern a distinct G0/G1 peak is found in the 
(near-)diploid (2C; 0.9<DI<1.1) region with a small proportion of cells in S and 
G2/M (4C) mode, as in normal tissue. This type of DNA ploidy pattern has been 
called a type I DNA-histogram by Auer et al (2). In polyploidy distinct peaks 
were present in the diploid and tetraploid (4C; 1.8<DI<2.2) regions, or in the 
diploid, tetraploid and octaploid (8C; 3.6<DI<4.4) regions. Very few cells or none 
at all had DNA values corresponding to the DNA synthesis phase of normal cells. 
This pattern corresponds with the type II DNA-histogram by Auer et at. Ploidy 
patterns were considered aneuploid in all other cases. These patterns combine 
the features of the Auer DNA histograms types III and IV. 
2.5c and 5c exceeding rate. 
An additional description of the DNA distribution in the PEC and CS specimen, 
was obtained by calculation of the 2.5c and 5c exceeding rates. These were 
defined as the percentages of cell nuclei having DI values of DI > 1.25 and 
DI > 2.5, respectively. 
Statistical Analysis. 
Differences in the DNA ploidy patterns and in the exceeding rates of CS and 
PEC specimen were tested using the paired t-test or signed rank test (Wilcoxon), 
depending of the distribution of the feature values. The correspondence between 
ploidy patterns was analyzed by rank correlation coefficients. For the high resoluti-
on cytophotometric analysis the Pearson correlation coefficients were calculated 
to test the relationship between the corresponding features in the CS and PEC 
specimen. This was performed in the complete groups of lesions and in two 
subgroups of nuclei. These subgroups (containing at least 15 nuclei per subgroup) 
were: a) (near-)diploid nuclei with DI values between 0.8 and 1.2, and b) (near-
)tetraploid nuclei with DI values between 1.6 and 2.4. These subgroups were 
chosen assuming that they contained comparable subpopulations for both prepara-
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tion techniques. The influence of a shift towards different ploidy-levels that might 
appear as a consequence of differences between both techniques, could as such 
be reduced. 
RESULTS 
DNA ploidy analysis. 
Table 2 shows the results of the DNA ploidy analysis in PEC and CS specimen 
of CIN III lesions. 
Table 2: Results of DNA ploidy analysis of corresponding cylological smears (CS) and cytospm 
specimen derived from paraffin-embedded tissues (PEC), both representing CIN ΠΙ lesions. 
PEC 
Diploid Polyploid Aneuploid Total 
CS 
Diploid 
Polyploid 
Aneuploid 
Total 
0 
3 
1 
4 
0 
5 
4 
9 
0 
0 
9 
9 
0 
8 
14 
22 
In the 22 PEC specimen four (18%) cases were classified as diploid; nine (41%) 
cases were polyploid and nine (41%) cases were aneuploid. In the corresponding 
22 CS specimen no diploidy occurred. Eight (36%) specimen showed polyploidy 
and fourteen (64%) were aneuploid. The visual classification of the ploidy patterns 
of the corresponding PEC and CS specimen were in agreement in fourteen cases. 
There was a significant (p<0.001) correlation of 0.62 between the corresponding 
ploidy patterns obtained by the two sampling techniques. 
Figures 3 and 4 give examples of comparable polyploid and aneuploid DNA 
patterns in corresponding PEC and CS specimen. 
In eight cases there was no agreement between the corresponding ploidy patterns. 
The four CIN III lesions that were classified as diploid in the PEC specimen, 
showed a polyploid pattern in three cases of the CS specimen and a aneuploid 
pattern in one case. 
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FREQUENCY FREQUENCY 
0 1 2 3 5 6 7 0 1 2 Ì 4 5 6 7 В 
DNA index 
Figure 3 Polyploid DNA pattern of a CIN III lesion in corresponding PEC (left histogram) 
and CS (right histogram) specimen 
FREQUENCY 
2 3 4 5 6 7 
DNA index 
0 1 2 Э 4 1 6 
DNA index 
Figure 4 Aneuploid DNA pattern of a CIN III lesion in corresponding PEC (left histogram) 
and CS (right histogram) specimen 
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In figure 5A and 5B the results of a case are presented that showed diploidy in 
the PEC specimen and a polyploid pattern in the CS specimen. An explanation 
for these findings might be that in the CS specimen exclusively the diagnostic cells 
were selected and measured, while in the PEC specimen cells were randomly 
selected and measured. This links up with the finding that the DNA ploidy pattern 
changed towards polyploidy/aneuploidy, if in the diploid PEC specimen exclusively 
the severe atypical ("diagnostic") cell nuclei were selected and remeasured, as is 
illustrated in figure 5C. 
FREQUENCY 
0 1 2 3 4 5 1 2 3 4 5 
DNA l n d « H 
Figure 5: A: Diploid DNA pattern of a CIN III lesion in the PEC (left histogram) specimen. 
B: Polyploid DNA pattern of a CIN III lesion in the corresponding CS (middle 
histogram) specimen. 
C: Scattered DNA ploidy values of the PEC (right histogram) specimen, after 
selective measuring. 
Five of the nine cases of polyploidy as measured in the PEC specimen, were 
also classified as polyploid in the CS specimen. Four were classified as aneuploid. 
In these latter four cases, the change of ploidy pattern was initiated by the 
presence of a clear aneuploid fraction of cells in the 6-7c (DI=3-3.5) area, as is 
illustrated in figure 6. All PEC specimen that were classified as aneuploid, 
demonstrated also aneuploidy in the cytological smears. In general there was a 
significant (p< 0.005) shift from diploid patterns towards polyploidy and aneuploidy 
and from polyploidy towards aneuploidy, in PEC specimen and CS specimen 
respectively. 
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Figure 6: DNA ploidy patterns of a CIN III lesion in corresponding PEC and CS specimen: 
polyploid pattern in PEC (left histogram) and aneuploid pattern in CS specimen (right 
histogram). 
The 2.5c and 5c exceeding rate. 
Figure 7 demonstrates the results of the 2.5c (DI = 1.25) and 5c (DI 
exceeding rate analysis of the 22 PEC and CS specimen. 
= 2.5) 
2 . 5 C E X C E E D I N G RATE: 5 C EIXCEEDXNG RATE 
Figure 7: Distribution of the 2.5c and 5c exceeding rate of 22 cases of corresponding PEC and 
CS specimen, both representing CIN III lesions. 
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The mean percentage of nuclei, that had DNA values exceeding 2.5c in the PEC 
specimen, was 59%, and ranged between 5% and 93%. In cytological smears the 
mean percentage of the 2.5c exceeding rate was 91%, and the range was 54%-
100%. The mean percentage of PEC nuclei exceeding 5c was 14%, ranging 
between 1% and 48%. In the cytological smears this percentage was 42%, ranging 
from 1% to 93%. The 2.5c and 5c exceeding rate of the CS specimen were 
significantly higher then those of the PEC specimen (p<0.0001). For 19 cases the 
2.5c exceeding rate was highest in CS specimen; they were identical in CS and 
PEC in two cases and highest in PEC specimen in one case. For the 5c exceeding 
rate these figures were: 19, one and two cases respectively. 
High resolution cytophotometric analysis. 
The Pearson correlation procedure, using the specimen mean and standard 
deviation values of 21 photometric features, was performed in the complete 
group of 22 cases, in a subgroup of cases with cell nuclei, that were in the (near)-
tetraploid DI value area and in a subgroup of cases with cell nuclei, that were 
in the (near-)diploid DI value area. The results of the analysis in the complete 
group of specimen indicated that there was a significant correlation between PEC 
and CS specimen for just three features: the mean and standard deviation of 
AREA and the mean of DNA-INDEX (ρ < 0.05). In the subgroup of (near-)tetra-
ploid cell nuclei no correlation between the corresponding specimen feature 
values was found. The correlation analysis that was performed in the (near-)diploid 
subpopulation indicated that three specimen mean feature values (LRL, RFC and 
INVCON) correlated in the PEC and CS specimen. However only 4 of the 22 
specimen had sufficient (N> = 15) (near-)diploid cell nuclei in both the PEC and 
CS specimen. To analyze the differences between the feature values of the (near)-
tetraploid subgroups of the PEC and CS specimen a paired t-test or signed rank 
test was performed. The results showed significant differences (p< 0.005) between 
the feature values of PEC and CS specimen concerning the specimen mean and 
standard deviation values of six features (LRL, RPC, CONTR, DMOM2, CIRC 
and GMRAT), and the specimen mean values of another eight features (SRL, 
OLD, HOMOG, INVCON, ENTRO, DMOM1, TRIS Y and MASSEC) (Table 3). 
The highest values for the mean and standard deviation of RPC, CONTR and 
DMOM2 and for the mean values of SRL, ENTRO, DMOM1, TRISY, CIRC and 
MASSEC were found in the CS specimen. The highest values for the mean and 
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standard deviation of LRL and GMRAT, for the mean values of HOMOG and 
INVCON and the standard deviation of CIRC were found in the PEC specimen. 
Table 3: Mean (M) and standard deviation (S) values of nuclear photometric features of (near)-
tetraploid (1.6<DI<2.4) subgroups of nuclei from PEC and CS specimen, both representing CIN 
III lesions (N = 19; highest values of significantly different features are underlined). * 
M.SRL 
M.LRL 
M.GLD 
M.RLD 
M.RPC 
M.HOMOG 
M.CONTR 
M.INVCON 
M.ENTRO 
M.MXTRP 
M.DMOM1 
M.DMOM2 
M.TRISY 
M.DI 
M.ADI 
M.SDDI 
M.M3DI 
M.AREA 
M.CIRC 
M.GMRAT 
M.MASSEC 
S.SRL 
S.LRL 
S.GLD 
S.RLD 
S.RPC 
S.HOMOG 
S.CONTR 
S.INVCON 
S.ENTRO 
S.MXTRP 
S.DMOM1 
S.DMOM2 
S.TRISY 
S.DI 
S.ADI 
S.SDDI 
S.M3DI 
S.AREA 
S.CIRC 
S.GMRAT 
S.MASSEC 
PEC 
MEAN 
0.27 
107 
0.19 
0.15 
0.15 
0.046 
0.98 
0.71 
1.43 
0.098 
3.19 
0.32 
0.09 
1.98 
0.0010 
0.0004 
0.0008 
2280 
0.76 
U 
0.45 
0.083 
48 
0.06 
0.06 
0.04 
0.0056 
0.30 
0.043 
0.054 
0.008 
0.54 
0.059 
0.042 
0.17 
0.00027 
0.00014 
0.00025 
625 
0.059 
1.14 
0.019 
ST.DEV. 
0.06 
39 
0.04 
0.03 
0.03 
0.005 
0.24 
0.04 
0.05 
0.004 
0.44 
0.05 
0.02 
0.12 
0.0003 
0.0002 
0.0003 
560 
0.03 
0.5 
0.01 
0.015 
13 
0.04 
0.03 
0.01 
0.0009 
0.08 
0.007 
0.007 
0.002 
0.09 
0.011 
0.019 
0.04 
0.00012 
0.00006 
0.00010 
175 
0.008 
0.26 
0.004 
CS 
MEAN 
0.37 
59 
0.15 
0.16 
0.21 
0.039 
1.46 
0.66 
1.50 
0.092 
3.93 
0.41 
0.12 
2.05 
0.0013 
0.0005 
0.0009 
1795 
0.81 
1.9 
0.47 
0.070 
31 
0.03 
0.04 
0.052 
0.0053 
0.45 
0.047 
0.058 
0.008 
0.63 
0.074 
0.045 
0.20 
0.00040 
0.00015 
0.00028 
565 
0.048 
0.71 
0.022 
ST.DEV. 
0.04 
19 
0.01 
0.01 
0.03 
0.003 
0.23 
0.02 
0.03 
0.003 
0.34 
0.04 
0.02 
0.08 
0.0003 
0.0001 
0.0002 
565 
0.02 
0.2 
0.01 
0.017 
11 
0.02 
0.01 
0.006 
0.0012 
0.05 
0.007 
0.009 
0.001 
0.08 
0.009 
0.011 
0.03 
0.00015 
0.00005 
0.00009 
185 
0.010 
0.21 
0.002 
* Significance level of the paired t-test or signed rank test (Bonferroni correction): a = 0.0012. 
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The morphologic translation of these cytophotometric findings was that CIN III 
nuclei in CS specimen appear to have on the average a more finely (and less 
coarse) granular chromatin, a higher contrast between the chromatin particles, 
more DNA margination, a more rounded shape and less variation in shape. 
Furthermore the nuclei in the CS specimen appear to have more variation in 
graininess and in contrast between the chromatin particles. 
DISCUSSION 
The aim of the present study was to compare DNA-measurements of corres-
ponding CIN III lesions in cytological smears and cytospin specimen, derived from 
paraffin-embedded tissue. The results of DNA ploidy analysis showed that there 
was a significant correlation between ploidy patterns of the two types of sampling-
/preparation techniques. There was however a significant shift from diploidy 
towards polyploidy/aneuploidy and from polyploidy towards aneuploidy in PEC 
and CS specimen respectively. This finding was supported by the results of the 
analysis of the 2.5c and 5c exceeding rate, that indicated a significantly higher 
percentage of cells with a higher DNA content in CS specimen. 
In respect to these differences between corresponding PEC and CS specimen the 
following considerations were made. 
1) The problem of sample representatively and cell selection. In PEC speci-
men the complete region of the CIN III lesion was selected in the thick paraffin-
embedded tissue sections, and as such cells from the intermediate and basal layers 
of the epithelium were also thought to be present. The cell nuclei were therefore 
randomly measured. Despite this selection a small number of normal cervical 
epithelial and stromal cells may still have been present in PEC specimen, thus 
influencing the outcome of the measurements. Cervical smears were taken with 
a wooden spatula and were thought to render mostly superficial cells, with a large 
admixture of cervical normal epithelial and inflammatory cells. The selection and 
measurement of CIN III cells in CS specimen was based on the presence of 
diagnostic CIN III cell nuclei, according to criteria regarding to size, shape and 
chromatin pattern of the nuclei (22). Random selection and measurement of nuclei 
in CS specimen is not appropriate because of the varying admixture with inflam-
matory and epithelial cells. If the cell nuclei in the PEC specimen, were selected 
according to the same diagnostic criteria as used for the CS specimen, the results 
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of ploidy analysis of the PEC specimen changed towards the pattern as found for 
the CS specimen. These findings could indicate that in CS specimen a "superselec-
tion" of CIN III nuclei with a higher DNA content was carried out and that the 
lower-ploid cell nuclei were discarded. It is possible that these lower-ploid cell 
nuclei do contribute to the potential progressive behavior of the CIN III lesion. 
In this respect it is of interest that earlier studies have shown that patients with 
cervical squamous cell carcinoma with a low ploidy level seemed to have a less 
favorable prognosis than patients with a more aneuploid DNA pattern (1,19). 
2) Another reason for the dissimilarity between the results of cytometrical 
analysis of CS and PEC specimen can be the different processing of the specimen. 
In this respect pitfalls concerning fixation, staining, functional differences between 
cells and instrumentation have been indicated by studies by Auer et al, Schulte 
et al, Mayall and Giroud et al (3,12,20,26). In the present study the staining 
procedures and the measurement instrumentation were similar for the CS and 
PEC specimen. The cell samples were from the same patients and arguably from 
the same lesions. Therefore it seems likely that, beside the cell selection bias as 
mentioned above, our present findings may be explained by differences in the fixa-
tion steps of the CS and PEC specimen. In this respect it is of interest to realize 
that acid hydrolysis as used in the Feulgen reaction gives a significant loss of 
protein in ethanol-acetone-fixed cells as compared to formalin-fixed cells (3,12,26). 
These factors may influence the chromatin structure and in turn influence the 
DNA stainability. Our present findings of low correlation for cytophotometric 
analyzed nuclear chromatin features in the complete groups of PEC and CS speci-
men and for the subpopulations of (near-)tetraploid cells add to these earlier 
findings. The morphologic translation of the differences in the (near-)tetraploid 
cell nuclei in the PEC and CS specimen are in agreement with earlier observati-
ons, that formalin fixed cell nuclei tend to have a more coarse chromatin pattern 
than alcohol-based fixatives. The mean AREA value in PEC specimen was higher, 
although not statistically significant, than in CS specimen. This adds to earlier find-
ings of Baak et al and Fox who noted that formaldehyde fixation gave little 
shrinkage of tissues and nuclear area (4,9). Another variable that may influence 
the outcome of the comparison of CS and PEC specimen is the enzymatic 
isolation procedure as used for the paraffin-embedded tissues. A selective loss of 
nuclear DNA or of entire nuclei may take place during enzymatic treatment (3). 
In summary the results of the present cytophotometric study of corresponding 
CS and PEC specimen, both representing CIN III lesions, indicate that DNA 
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ploidy patterns of corresponding CIN III lesions show a significant correlation. 
The 2.5c and 5c exceeding rates of CS specimen are however significantly higher 
in the vast majority of cases. The high resolution cytophotometric analysis of a 
subgroup of (near-)tetraploid cell nuclei in CS and PEC specimen showed signifi­
cant differences for the majority of nuclear photometric features. These differences 
could possibly be explained by the variance in selection of CIN III cells, and by 
the differences between the fixation steps as used in the CS and PEC procedures. 
As a consequence it is concluded that cytophotometric data of CS and PEC speci­
men representing CIN III lesions should not be regarded as interchangeable 
among each other. 
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A.E. van 't Hof-Grootenboer, J.H. Gemmink, H. de Leeuw 
Abstract DNA ploidy analysis, 2.5C and 5C exceeding rates and high resolution 
cytophotometric analysis were performed in 73 cervical cytological smears with 
cytologial diagnosis of CIN I, II, III and invasive carcinoma from 57 women, to 
identify prognostic parameters. From four cervical screening registries a group of 
28 women was selected on basis of a final histologic diagnosis of cervical invasive 
squamous cell carcinoma, with previous cervical smears consistent with CIN I, 
II and III lesions and who were left untreated. A second group of 29 patients, 
who were treated for cytologically diagnosed CIN III was regarded to represent 
a mixture of progressive, persistent and regressive lesions. In 64% of cervical 
smears from the group of patients who had developed invasive cancer, a DNA-
aneuploid pattern was found both in CIN and in invasive lesions. DNA polyploidy 
was present in 36% of both of these lesions. It was concluded that DNA polyp-
loid CIN lesions should not be regarded as possibly reactive or regressive. DNA 
diploidy did not occur in these CIN or invasive cancer cases. The 2.5C exceeding 
rate increased with increasing severity of the CIN lesion. A high resolution cyto-
photometric analysis demonstrated a trend-like pattern of a number of feature 
values in lesions with increasing severity, thus from CIN I and CIN II to CIN III 
and invasive cancer. In a cluster analysis based on the results of high resolution 
cytophotometric analysis, a subdivision of CIN III lesions with unknown malig-
nant potential was possible into a group of lesions with similar feature values as 
a group of progressive CIN III and a second group of lesions that had feature 
values that were dissimilar to progressive CIN III. It was suggested to apply a 
classifier based on a combination of age, high resolution cytophotometric data and 
ploidy patterns in a prospective study of cytologically detected CIN-lesions. 
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INTRODUCTION 
The natural history of premalignant cervical lesions has not been solved. There 
are considerable differences in the results of follow-up studies, depending on issues 
like different follow-up period, the taking of biopsies during follow-up period, 
different interpretation of cytologic and histologic aspect, and different statistical 
approaches (4,8,9,13,15,25,27-29,31,35,36,38,39,43). In an overview article, Koss 
recently stated that at the most one in ten cervical precancerous lesions is likely 
to progress to invasive cancer, when left untreated (26). It is however not pos-
sible to predict by cytopathologic, histopathologic or colposcopie examination which 
cervical intraepithelial neoplasia (CIN) will finally become invasive. As a conse-
quence all cases of CIN are being treated as premalignant, potentially progressive 
lesions. 
As a possible tool to predict the malignant potential of CIN, cytogenetic and 
cytometric DNA studies have been considered. Cytogenetic studies in cervical 
biopsy specimen have indicated that aneuploidy is frequent in CIN II and III 
lesions, although (near-)diploidy does occur (1,2,24,41). It was mentioned that 
carcinoma in situ may have undergone less chromosomal loss and fewer structural 
changes than invasive cervical carcinoma, that often appeared to be near-triploid 
(2). Spriggs and coworkers in a study of 28 cases of CIN and microinvasive 
carcinoma, concluded that no chromosomal features were distinctive of dysplasi-
a, carcinoma in situ, microinvasive or invasive carcinoma (41). Microspectrophoto-
metric, flow and image cytometric DNA ploidy measurements have increasingly 
been performed in cervical scrapings, in fresh biopsy material and in paraffin 
sections (5-7,10,11,14,16,17,23,30,32,40,45). Some investigators have indicated that 
CIN with an aneuploid DNA pattern has a higher rate of persistence or recurren-
ce than lesions with a diploid or polyploid pattern (6,11,32). In other studies 
however no significant differences could be demonstrated between CIN II lesions 
that progressed to carcinoma in situ and those that regressed to normality (30). 
In a study of DNA-measurements in nuclei, isolated from paraffin-embedded CIN 
III and CIN Ill-like lesions adjacent to invasive squamous cell cancer (CIN-INV), 
we showed that DNA-diploidy did occur in CIN lesions, especially in a group of 
younger patients with CIN Ill-like lesions adjacent to invasieve cancer (16). This 
finding correlated with data that showed that about half of the cases of cervical 
invasive squamous cell carcinoma were (near-)diploid (2,17). 
A recent high resolution cytophotometric analysis of nuclei retrieved from paraffin-
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embedded CIN III and CIN.INV lesions, using texture, density and geometry 
features, indicated that in the group of CIN III lesions a subgroup of lesions was 
present with similar photometric feature values as in the vast majority of CIN.INV 
lesions, indicating a possible progressive potential of these CIN III lesions. These 
results showed that high resolution cytophotometric analysis may be of help in 
the distinction between progressive and non-progressive cervical intraepithelial 
lesions (18). 
For the present study, 73 cervical cytologic smears were selected. 44 were cervical 
smears from patients who, after an initial cervical smear after a variable interval 
and without intermittend treatment, developed cervical invasive squamous cell car-
cinoma (INV). These cervical smears were used in DNA-ploidy analysis and a high 
resolution cytophotometric analysis. The aim of the study was to describe DNA 
ploidy patterns, 2.5c and 5c exceeding rates and high resolution cytophotometric 
feature values in progressive CIN I, II, III and INV lesions. Furthermore it was 
aimed to test previous findings of features indicating a possible progressive 
potential on CIN III lesions with a known progressive course and to analyze 
whether these features would identify subgroups in CIN III lesions with an 
unknown biological behavior because of intercurrent treatment. 
MATERIAL AND METHODS 
Patient group. 
From four cervical screening registries a group of 28 women was selected on the 
basis of a final histologic diagnosis of cervical invasive squamous cell carcinoma, 
having had previous cervical smears (CS), consistent with CIN I, II or III lesions 
(table 1) and who were left untreated. The original cytologic cervical smears had 
been misinterpreted as negative or showing only minor abnormalities or the 
patients had been lost to follow-up. The histologic diagnosis was microinvasive 
carcinoma (stage 1A) in five cases and macroinvasive carcinoma (stage IB or 
higher) in 23 cases. The mean time interval between the cytologic and histologic 
diagnosis was 30 months for the microinvasive carcinomas and 33 months for the 
macroinvasive carcinomas. The CIN lesions of these 28 patients are labelled with 
the prefix "p" for their progressive course (pCIN I-III). 
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Table 1: Distnbulion of cervical smears, subdivided for the 57 patients according to the different 
combinations of cytologic diagnosis. 
No. of 
patients 
1 
1 
2 
3 
8 
1 
1 
9 
2 
Total 28 
(progr) 
Total 29 
(unknown) 
Total 57 
D CIN I 
1 
1 
2 
1 
5 
5 
ρ CIN II 
1 
3 
1 
5 
5 
E 
u 
CIN IH 
1 
2 
3 
8 
9 
23 
CIN 
29 
52 
л 
INV 
1 
8 
2* 
11 
11 
No. of 
smears 
3 
2 
4 
б 
16 
1 
1 
9 
2 
44 
29 
73 
* The corresponding previous CIN lesions contained less than 20 measurable cells and were 
discarded from the study. 
A second group of 29 patients was selected, who were treated for cytologically 
diagnosed CIN III at the University Hospital Nijmegen. This group of CIN III 
lesions was regarded to represent a mixture of progressive, persistent and regressi­
ve lesions (18). The CIN III lesions of these patients are further indicated by the 
prefix "u" for unknown progressive potential (uCIN III). 
Cytologic material. 
Cytologic smears had been routinely prepared by scraping the surface cervical 
mucosa with a wooden spatula. The material was then put on slides and fixed. 
For routine diagnostic purposes the slides were stained according to the Papanico­
laou technique. The cytologic diagnosis made at rescreening, was based on the 
presence of singly lying or clusters of atypical cells that were regarded as diagnos­
tic for CIN I, II, III or INV lesions. Usually normal superficial and intermediate 
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epithelial cells and inflammatory cells were also present in these slides. For 
cytophotometric analysis the coverslips of the slides were removed using xylol and 
the specimens were then rehydrated according to the following sequence, ethanol 
96% (twice), ethanol 70%, ethanol 40% and distilled water. Thereafter specimens 
were fixed in a mixture of methanol, 37% formaldehyde and acetic acid (85-10-
5 by volume) for one hour, rehydrated, treated with acid hydrolysis (5 N HCL) 
at 22° С for 60 minutes and stained with the Pararosanilin (Schiff)-Feulgen stain. 
No cytoplasmic counterstain was used. A mean number of 129 (range 23-200) 
diagnostic cells per specimen was selected for measurements. As an internal 
control from each specimen 20 cervical intermediate squamous cells were measu­
red. The median values of integrated optical densities (MD.IOD) of intermediate 
cells, present in the 73 samples, ranged from 78 to 268 (mean: 196). The mean 
value of the coefficients of variation of the controls was 11,7%. 
Digitization. 
Nuclei of the cytologic smears were measured with the Nijmegen Image Analysis 
System (NIAS). The NIAS system is composed of an Orthoplan (Leitz Wetzlar, 
W.-Germany) scanning microscope, equipped with a linear diode array (Fairchild, 
USA), which was interfaced to a MINC minicomputer with a LSI 11/23 micropro­
cessor (Digital Equipment Corp., Manyard, MA). Pararosanilin (Schiff)-Feulgen 
stained nuclei were measured with monochromatic light at a wavelength of 565 
nm (band width 20 nm), using a 40x objective. The sampling density was four 
pixels per micrometer. Nuclei were automatically located in the digital images by 
grey level boundary following. 
Twenty-one nuclear features, describing geometry, density and texture were 
extracted from the digitized nuclear images (12,20,33,34,37). The DNA content 
of nuclei was expressed as DNA-index (DI), defined as the integrated optical 
density of a nucleus divided by the median value of integrated optical densities 
of internal control nuclei. For each specimen mean and standard deviation of all 
nuclear features were calculated and used as "specimen features". 
Interpretation of DNA histograms. 
DNA histograms were displayed using a bin-size of 0.1. DNA ploidy patterns were 
visually classified as DNA-diploid, DNA-polyploid, or DNA-aneuploid, according 
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to the following definitions (3,17,21,22). In a DNA-diploid pattern a distinct 
G0/G1 peak is found in the (near-)diploid (2C; 0.9<DI<1.1) region with a small 
proportion of cells in S and G2/M (4C) mode, as in normal tissue. In DNA-
polyploidy distinct peaks were present in the diploid and tetraploid (4C; 
1.8<DI<2.2) regions, or in the diploid, tetraploid and octaploid (8C; 3.6<DI<4.4) 
regions. Very few cells or none at all had intermediate DI values. Ploidy patterns 
were considered DNA-aneuploid in all cases with scattered DI distributions, or 
uni-, bi-, or multimodal DI distributions, that were non-diploid and non-polyp-
loid. 
2.5c and 5c exceeding rales. 
The 2.5c and 5c exceeding rates (ER) were defined as the percentages of cell 
nuclei per specimen, with DI values of DI > 1.25 and DI > 2.5, respectively. 
Statistical Analysis. 
The first aim of the study was to describe DNA ploidy patterns, 2.5c and 5c 
exceeding rates and cytophotometric feature values in progressive CIN I, II, III 
and in INV lesions. Non-parametric tests were used to find differences in excee-
ding rates and cytophotometric feature values. A trend in feature values with 
increasing severity of the diagnosis, was tested using the Terpstra test. 
The second aim of the study was to determine if the group of uCIN III lesions 
could be subdivided into two subgroups: 1) a group of lesions with similar feature 
values to the group of pCIN III lesions and as such possibly representing potenti-
ally progressive lesions, 2) a group of lesions with feature values dissimilar to the 
pCIN III lesions. A stepwise linear discriminant analysis was performed, to select 
features that could discriminate between uCIN III and pCIN III lesions, assuming 
these to be good candidates for discrimination of the two subgroups. The stepwise 
discriminant analysis was based on all 42 mean (M) and standard deviation (S) 
feature values (after an adequate transformation to "normality") of individual 
patients. Ward's cluster analysis was carried out using the best discriminating M 
and S features from the stepwise discriminant procedures and using a set of 
features as used in a previous study of CIN III lesions (18,42,44). The Ward 
procedure implies the use of standard deviation-scores of the features. The 
clustering procedure aimed to reach a division of the uCIN III group under the 
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condition that the pCIN III group was not further subdivided. In this manner 
uCIN III lesions could be identified, that had corresponding feature values to the 
pCIN III group. 
RESULTS 
Description of pCIN I, II, III and INV. 
DNA ploidy analysis. 
The results of DNA ploidy analysis in cytologic smears from 33 progressive CIN 
(5 pCIN I, 5 pCIN II and 23 pCIN III) and from 11 INV lesions are shown in 
table 2. In these pCIN and INV lesions DNA-diploidy did not occur. Four of the 
five pCIN I specimen were classified as DNA-polyploid and one as DNA-aneup­
loid. Two of the five pCIN II specimen showed a polyploid and three an aneup-
loid DNA pattern. Six (26 %) of 23 pCIN III lesions were DNA-polyploid and 
17 (74 %) were DNA-aneuploid. This showed a slight predominance of DNA-
polyploidy in pCIN I and of DNA-aneuploidy in pCIN II and pCIN III. In the 
complete group of pCIN I-III lesions DNA-aneuploidy occurred in 21 cases (64 
%), and DNA-polyploidy in 12 cases (36 %). The same ratio applied for the 
cytologic specimen from invasive carcinomas: four (36 %) cases were DNA-
polyploid, seven (64 %) were DNA-aneuploid. 
Two or more successive smears could be analyzed in 15 patients with progressive 
lesions (table 1 and 3): in eight patients with successive pCIN III and INV 
specimen, in three patients with pCIN II and pCIN III specimen, in two patients 
with pCIN I and pCIN III specimen, and in one patient with pCIN I and pCIN 
II. In one patient a pCIN I, pCIN III and an INV specimen were measured. 
The classification of the DNA-ploidy patterns of the successive specimen were in 
agreement in 11 (73%) cases, including the case with three successive smears. 
Figure 1 shows examples of DNA-ploidy patterns in three patients with successive 
CIN and INV lesions. In figure 1A the polyploid DNA patterns of pCIN III and 
INV lesions of patient no. 3 are shown. Figure IB demonstrates a DNA-aneuploid 
pattern of pCIN III and a DNA-polyploid pattern of INV of patient no. 7. Figure 
1С presents DNA-aneuploid patterns of patient no. 9 with successive pCIN I, 
pCIN III and INV lesions. This figure further illustrates that DNA-aneuploid 
patterns in successive smears are not necessarily identical. 
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Table 2: Results of DNA ploidy analysis of all cytologic smears, representing pCIN I, pCIN II, pCIN 
III, INV and uCIN III lesions.* 
pCIN I 
pCIN II 
pCIN III 
Tot.pCIN I-III 
INV 
uCIN III 
Total 
Diploid 
-
-
-
-
-
1 (3%) 
1 
Polyploid 
4 (80%) 
2 (40%) 
6 (26%) 
12 (36%) 
4 (36%) 
15 (52%) 
34 
Aneuploid 
1 (20%) 
3 (60%) 
17 (74%) 
21 (64%) 
7 (64%) 
13 (45%) 
38 
Total 
5 
5 
23 
33 
11 
29 
73 
* pCIN I-III = CIN I-III lesions of patients who have developed an invasive squamous cell 
carcinoma. uCIN III = CIN III lesions with unknown progressive potential. 
0 1 2 3 
FREQUENCY 
« 4 
0 1 2 3 4 5 6 
DNA i n d e x 
Figure 1 A: DNA-polyploid patterns of CIN III (left histogram) and INV (right histogram) lesions 
of one patient (patient no. 3). 
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rftEOUENCY 
Figure IB· Aneuploid DNA-patterns of CIN III (left histogram) and a polyploid DNA-pattern 
of INV (right histogram) lesion of one patient (patient no 7). 
FREQUENCY 
Figure 1С: Aneuploid DNA-patterns of the successive CIN I (left histogram), CIN HI (middle 
histogram) and INV (right histogram) lesion of one patient (patient no. 9) In the CIN I lesion 
three stemlines seem to be present with near-dtploid peaks at DI = 0 7, 0 9 and 1.1. In the ncar-
tctraploid region also three peaks with DI values of 1.6, 2.2 and 2 8. In the near-octaploid region 
two smaller peaks with DI values of 3.2 and 4.1. In the CIN III and INV lesions this pattern is 
not as obvious, with, for CIN III, peaks mainly in the near-tetraploid region at DI = 1.9, 2 3 and 
perhaps at 2.5, and with three small adjacent peaks at DI = 3 0, 3 3, and 3 6. In the INV lesion 
the main peaks are at DI = 1.7 (possibly also at 1.5 and 2.4), 3.1 and 3.6. 
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Table 3 Age, cytologic and histologic diagnosis ploidy pattern, 2 5c and 5c ER in cytologic smears, 
representing successive progressive cenical intraepithelial neoplasia grade I-III (pCIN I-III) and 
invasive squamous cell carcinoma (INV) of 15 patients 
Patient Age 
No. 
3 58 
4 47 
5 35 
6 32 
7 49 
8 32 
9 35 
10 37 
12 37 
14 43 
15 27 
17 60 
18 42 
26 39 
27 47 
Year of 
diagnosis 
1974 
1978 
1978 
1977 
1980 
1980 
1976 
1980 
1980 
1978 
1981 
1981 
1978 
1981 
1981 
1977 
1980 
1981 
1977 
1981 
1982 
1982 
1975 
1976 
1981 
1979 
1983 
1983 
1981 
1983 
1983 
1980 
1983 
1983 
1976 
1977 
1977 
1973 
1978 
1980 
1976 
1981 
1981 
1980 
1983 
1983 
Cytologic 
diagnosis 
CIN III 
INV 
CIN HI 
INV 
CIN III 
INV 
CIN III 
INV 
CIN III 
INV 
CIN II 
CIN III 
CIN I 
CIN III 
INV 
CIN II 
CIN III 
CIN III 
INV 
CIN III 
INV 
CIN I 
CIN III 
CIN I 
CIN III 
CIN II 
CIN III 
CIN I 
CIN II 
CIN III 
INV 
Histologic 
diagnosis 
INV 
INV 
INV 
INV 
INV 
INV 
INV 
INV 
INV 
INV 
INV 
INV 
INV 
INV 
INV 
Ploidy pattern 
Polyploid 
Polyploid 
Aneuploid 
Aneuploid 
Polyploid 
Polyploid 
Polyploid 
Polyploid 
Aneuploid 
Polyploid 
Aneuploid 
Aneuploid 
Aneuploid 
Aneuploid 
Aneuploid 
Aneuploid 
Aneuploid 
Aneuploid 
Aneuploid 
Polyploid 
Aneuploid 
Polyploid 
Aneuploid 
Polyploid 
Polyploid 
Aneuploid 
Aneuploid 
Aneuploid 
Polyploid 
Aneuploid 
Aneuploid 
2.5c ER 
84 
84 
87 
100 
90 
94 
42 
88 
95 
33 
83 
98 
61 
98 
97 
100 
100 
99 
81 
80 
97 
53 
100 
89 
95 
88 
90 
91 
40 
88 
% 
5c ER 
15 
6 
26 
62 
6 
2 
15 
11 
47 
4 
7 
63 
24 
26 
37 
76 
69 
51 
25 
11 
20 
0 
53 
26 
11 
19 
27 
η 
1 
20 
49 
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Exceeding rates. 
The mean and standard deviation values of the 2.5c and 5c exceeding rates by 
diagnosis are illustrated m table 4. Nine patients with both CIN III and INV 
diagnosis were selected to test differences in exceeding rates between both 
diagnosis, using the (paired) Wilcoxon test. No differences were found. In order 
to avoid statistical dependencies, due to incidental repeated measurements within 
the same patients, differences between the combined CIN I+11 group and CIN 
III, were tested in two ways, using the Wilcoxon test on six pairs of smears (see 
table 1) and the Mann-Whitney test for nine smears (CIN I+II) against 17 smears 
(CIN III). The difference in 2.5c ER for CIN I+II against CIN III was of a 
borderline significance in both tests (p=0.07 and p=0.06 respectively). For 5c ER 
no significant differences were found 
Table 4 Mean and standard deviation (between brackets) of the 2 5c and 5c exceeding rates (ER) 
by diagnosis 
pCIN I pCIN II pCIN III INV 
2 5c ER 66(24%) 70(29%) 89(13%) 88(19%) 
5c ER 13 (13%) 22 (31%) 31 (22%) 29 (22%) 
High resolution cylopliotometnc analysis. 
Nine patients with both pCIN III and INV diagnosis were selected to test 
differences in feature values, using the (paired) Wilcoxon test. No differences were 
found. 
As applied for the ER values (see above), differences between the combined 
pCIN I+II group and pCIN III, were tested in two ways, using the Wilcoxon test 
on six pairs of smears (see table 1) and the Mann-Whitney test for nine smears 
(pCIN I+II) against 17 smears (pCIN III). For both tests the same features 
showed significant differences (M-massec, S-rpc, S-contr, S-invcon, S-entro, S-
dmoml and S-dmom2, Wilcoxon test p<0.03, Mann-Whitney test p<0.01). A 
subdivision of pCIN III lesions into lesions with a short or long (> 24 months) 
time interval prior to the histologic diagnosis of cancer did not influence this 
result. 
To study a trend in the cytophotometnc feature values with increasing severity, 
the Terpstra trend test was used on five pCIN I, five pCIN II and 17 pCIN III 
independent smears, all showing a decreasing value with severity. In table 5 the 
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mean and standard deviation values of these features in the groups of pCIN I, 
pCIN II and pCIN III are given. A translation of these findings into light micro­
scopical cytologic characteristics is that with increasing seventy of the progressive 
CIN, nuclei tend to have less finely granular chromatin, less contrast between 
the chromatin particles (equivalent to more overall internal contrast), less variation 
in contrast between the chromatin particles, and less DNA margination. 
Table 5 The 11 features having significant decreasing mean (M) and standard deviation (S) values 
of nuclear photometric features of pCIN I, pCIN II and pCIN III independent lesions 
M-srl 
M-rpc 
M-contr 
M entro 
M-dmoml 
M-dmom2 
M-massec 
S-rpc 
S-contr 
S-dmoml 
S-dmom2 
pCIN I 
N = 5 
M 
0 357 
0 200 
141 
149 
3 81 
0 398 
0 472 
0 0582 
0 491 
0 689 
0 0816 
S 
0 033 
0 023 
018 
002 
024 
0030 
0006 
00030 
0 023 
0 035 
0 0037 
pCIN II 
N = 5 
M 
0 344 
0179 
124 
147 
3 56 
0 369 
0 474 
0 0535 
0441 
0 682 
00772 
S 
0 028 
0027 
0 24 
0 03 
0 35 
0 040 
0009 
00082 
0091 
0 075 
0010 
pCIN III 
N=17 
M 
0 327 
0172 
117 
146 
3 46 
0 360 
0464 
0 0493 
0 391 
0 613 
00696 
I 
S 
0 030 
0 020 
017 
002 
0 26 
0 029 
0006 
0006 
0 056 
0 049 
00073 
Ρ* 
0 03 
0 03 
0 02 
004 
002 
004 
0 03 
0 01 
0 02 
002 
0009 
* p-valuc of the Terpstra trend test 
Compamon of pCIN III and uCIN III 
DNA ploidy patterns of the 29 uCIN III lesions of unknown progressive potential 
were diploid in one case (3%), polyploid in 15 (52%) cases and aneuploid in 13 
(45%) cases (Table 2). When compared with the ploidy patterns in pCIN III 
lesions (26 % DNA-polyploid and 74 % DNA-aneuploid) the DNA-polyploidy in 
uCIN III lesions was more frequent. The mean 2 5c ER value of the uCIN III 
lesions was 89 %, which was similar to that of the pCIN III lesions. The mean 
5c ER value of the uCIN III lesions was 26 %, that of the pCIN III lesions 31%. 
For the cluster analysis of pCIN III and uCIN III, at first those features were 
chosen, that were selected by the stepwise discriminant analysis (S-sdi, M- and 
S-gmrat, M- and S-circ and S-dmoml) With these features in the cluster analysis 
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no subdivision in clusters occurred. However, with the features which were 
selected in an earlier study, based on paraffin-embedded tissue, an indication of 
a subdivision in two clusters did occur (18). These variables included the standard 
deviation of a texture feature (S-homog), the standard deviation of a density 
feature (S-di), and the standard deviation (S-area) and mean value (M-circ) of 
two geometry features. The majority (91%) of pCIN III lesions was assigned to 
the same cluster (cluster 1). Of the uCIN III lesions 20 cases (69%) were assigned 
to this cluster 1. The 9 (31%) remaining uCIN III lesions were selected in the 
second cluster. The mean and standard deviation values of the clustering variables 
of the detected clusters are indicated in table 6. 
Table 6: The mean values (and standard deviation values between brackets) of the clustering variables 
of the detected clusters. 
S-homog 
S-di 
S-area 
M-circ 
0.0738 
0.83 
24.1 
0.824 
cluster 1 
(0.0033) 
(0.14) 
(3.8) 
(0.012) 
0.0805 
1.20 
33.3 
0.820 
cluster 2 
(0.0055) 
(0.16) 
(3.8) 
(0.012) 
A translation of these findings is that cluster 1 lesions have less variation in 
nuclear DNA-distribution, DNA-content and nuclear size, and have, on the 
average, more round nuclei. Translated into light microscopical terms these 
features could be descriptive of relatively small-rounded hyperchromatic nuclei, 
as seen in the relative uniform morphology of classical in situ lesions. Whereas 
a greater variability in size and chromatin distribution could be consistent with 
severely dysplastic changes. 
DISCUSSION 
The first aim of the present study was to describe DNA-ploidy patterns, 2.5c and 
5c exceeding rates and cytophotometric features values of progressive pCIN 
lesions. The results indicated that, with increasing severity the pCIN lesions 
developed a higher rate of DNA-aneuploidy, ranging from 20% in pCIN I lesions, 
to 74% in pCIN III lesions. In parallel 2.5c exceeding rates increased from 66% 
in pCIN I lesions to 89% in pCIN III lesions. These findings linked up with previ-
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ous data of Nasiell et al who showed that mild or moderate dysplastic lesions 
which progressed towards carcinoma in situ or microinvasive carcinoma, were 
invariably accompanied by a sequence of increasing abnormal DNA patterns (32). 
They further noted that in three patients with cervicitis as the final diagnosis, 
DNA patterns were constantly within normal limits. Our present results of DNA 
ploidy analysis and exceeding rates in individual patients with successive pCIN and 
INV lesions, however indicated that changes of DNA-aneuploidy into DNA-poly-
ploidy did occur with increasing severity of the lesions. Furthermore the fact that 
DNA-polyploidy did occur in the group of progressive CIN lesions and in the 
group of invasive cancer lesions, is in conflict with previous suggestions that 
DNA-polyploidy could be considered as indicative for regression in CIN lesions 
(6,11). In the present study DNA-polyploidy was found in cervical cytologic smears 
in CIN lesions which were proven to be progressive and in invasive lesions. There-
fore DNA-polyploid CIN lesions should not be regarded as possibly reactive or 
regressive. 
The finding that DNA-diploidy did not occur in the present group of cytologic 
smears, from progressive CIN lesions and invasive cancer, might add to the idea 
that DNA-diploidy in cervical smears demonstrates non-progressive "CIN" lesions, 
as was suggested earlier (6,11,32). This seems contradictory to earlier findings of 
DNA-diploidy in CIN III lesions (1,2) and in CIN Ill-like lesions adjacent to 
invasive cancer in cytospin specimen retrieved from paraffin-embedded tissues 
(16). Recently, however, it was shown that DNA cytometric data and thus ploidy 
patterns are strongly dependent on the way the cells of interest are sampled, from 
cervical cytologic smears (CS) or retrieved from paraffin-embedded tissue by 
enzymatic digestion (PEC) (19). It was shown that 2.5c and 5c exceeding rates 
were significantly higher in the vast majority of cytologic specimens. DNA-diploidy 
was seen in four cases of CIN III in cytospin specimen made from paraffin-
embedded tissue, while the corresponding cytologic smears showed polyploid and 
aneuploid DNA-patterns. These differences appeared to depend on the variance 
in selection of CIN III cells, using the CS or PEC sampling method. At light 
microscopical selection of cells from conventional cytologic smears it is understand-
able that the most abnormal looking cells are sampled by preference whereas in 
specimens made from selected areas from paraffin embedded tissue, all nuclei 
present in the cytospin specimen are accepted for analysis by the observer. 
Consequently cytophotometrical data from CS and PEC specimen from CIN III 
lesions can not be regarded to be interchangeable among each other (19). 
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The results of the high resolution cytophotometric analysis of the group of pCIN 
I-III and INV lesions showed that trend-like changes could be identified in lesions 
with increasing severity c.q. from pCIN I and pCIN II towards pCIN III and 
INV. The cyto-morphological translation of these findings was that with increa-
sing atypia of the progressive lesions, nuclei tended to have less finely granular 
chromatin, less contrast between the chromatin particles, less variation in contrast 
between the chromatin particles, and more DNA margination. Greatest differences 
were detectable when pCIN I/pCIN II lesions were compared with pCIN III/INV 
lesions. 
When comparing pCIN III and the uCIN III lesions, DNA-polyploidy occurred 
more often in uCIN III and the 5c exceeding rates were slightly lower in uCIN 
III, but differences regarding DNA ploidy patterns or the 2.5c or 5c exceeding 
rates were not significant. It was of interest that a cluster analysis performed on 
the basis of four photometric features that were previously used in the cluster 
analysis of CIN III and CIN III like lesions adjacent to invasive cancer, was 
applicable for the group of pCIN III and uCIN III (18). 69% of the uCIN III 
lesions were member of the same cluster 1, as the vast majority of the pCIN III 
lesions. The earlier high resolution cytophotometric study of CIN III and CIN.INV 
showed that 90% of CIN.INV lesions were member of one and the same cluster 
1, while 56% of the CIN III lesions with unknown progressive potential had 
cluster 1 feature values. These different studies indicated as such that CIN III 
lesions with unknown progressive potential could be subdivided in two subgroups, 
using high resolution cytophotometric analysis. Adding to these findings the present 
study showed that by high resolution cytophotometric analysis, a trend-like pattern 
could be described in CIN lesions with a progressive course. It may be considered 
to apply a classifier based on a combination of age, high resolution cytophotome-
tric data and DNA ploidy patterns, in a prospective study of cytologically detected 
CIN lesions. 
It is argued that the profile of progressive cervical intraepithelial lesions has 
become more clear and that it might be justified to follow in time those lesions 
that do not come up to this profile, without the patient taking risks when not 
treating the non-progressive lesions. 
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The natural history of premalignant epithelial lesions of the uterine cervix has 
not been solved. Cervical intraepithelial neoplasia (= CIN I-III or dysplasia and 
carcinoma in situ) may have a progressive course towards invasive cancer, but they 
may also persist or return to normal. Cytopathologic, histopathologic or colposco-
pie investigations have not been able to subdivide these lesions into progressive, 
persistent and regressive subtypes. As a consequence all patients are presently 
treated as having a potentially progressive lesion. 
A technique that could distinguish between potentially progressive and potenti-
ally persistent or regressive lesions would be of great value for the treatment of 
cervical abnormalities. The subject of the present study, was the significance of 
DNA cytometry of cervical intraepithelial neoplasia. 
In chapter 1 an overview of some of the literature is given, with some extra 
attention for the role of human papilloma virus infection as a possible progression 
marker. 
The aim of the study was to investigate the value of DNA cytometry for the 
discrimination between progressive and non-progressive cervical intraepithelial 
neoplasia. 
In chapter 2 a method is described, which was developed to extract nuclei 
from circumscribed epithelial regions in 50 micrometer sections of paraffin-embed-
ded tissue. The area of interest is isolated from these thick sections, by scraping 
off the non-relevant tissue with a scalpel under a dissection microscope. After ex-
traction of the nuclei in a protease solution and washing, the nuclei can be used 
for flow cytometric analysis and for image cytometric analysis, after being re-
suspended in foetal calf serum and cytocentrifugation. As examples of the tech-
nique flow and image cytometric measurements are presented of nuclei isolated 
from a) carcinoma in situ region and invasive carcinoma region in breast tissue, 
and b) from cervical intraepithelial neoplasias grade 3 (CIN III). 
The study, presented in chapter 3, reports on image (cytophotometric) and 
flow cytometric DNA ploidy analysis in nuclei isolated from selected CIN III areas 
of paraffin-embedded tissue of 20 patients with (CIN), and 19 patients without 
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(CIN.INV) synchronous cervical invasive squamous cell carcinoma. 21 patients 
were 35 years of age or younger and 18 patients were 50 years or older. DNA-
aneuploidy was about as frequent in the complete group of CIN lesions (53%) 
as in the CIN.INV group (50%). Differences in the distribution of DNA ploidy 
patterns between the two age groups were observed. The majority of CIN III 
lesions in women 50 years of age or older were aneuploid. This was observed 
in CIN III lesions with (70%) as well as without (88%) a coexisting invasive 
cancer. In the group of younger women a diploid DNA pattern was found in 
about 60% of the CIN Ill-like lesions with a concomitant invasive cancer. In the 
absence of an invasive cancer, CIN III lesions were mostly polyploid. The DNA 
patterns of invasive cancer were generally identical with the adjacent CIN Ill-
like lesions, thus suggesting the two lesions to be related. These results are at 
considerable variance with previously published data on DNA ploidy values in CIN 
lesions. As a consequence of these results the prognostic value of DNA ploidy 
measurements in cervical intraepithelial lesions in women of these two age groups 
had to be further evaluated. Parallel sections of all specimen were immunohisto-
chemically stained for human papilloma virus capsid antigen (HPV). HPV could 
be demonstrated in four CIN III lesions without invasive cancer, in women 35 
years of age or younger. In three of these a polyploid DNA pattern was present; 
the fourth case showed a bimodal aneuploid pattern. 
In chapter 4 DNA ploidy analysis and high resolution cytophotometric analysis 
were performed in a group of 37 CIN III lesions and 32 cases of cervical invasive 
squamous cell carcinoma (INV). Ploidy analyses, performed in nuclei isolated from 
selected CIN III and invasive cancer areas of paraffin-embedded tissue, showed 
DNA-aneuploidy to be about as frequent in the total group of patients with CIN 
III lesions (41%) as in the total group of patients with invasive (37%) lesions. 
When the patients were subdivided in two age groups, e.g. 45 years of age or 
younger and 46 years or older a relatively high percentage of DNA-diploidy was 
demonstrated in invasive lesions in the group of younger patients (73%). In CIN 
III lesions in younger women, DNA-polyploidy was relatively frequent (46%). In 
elderly women CIN III lesions showed the highest percentages of DNA-aneuplo-
idy (82%). 
The results of the high resolution cytophotometric analysis, based on twenty-one 
photometric features describing geometrical, density and texture characteristics of 
the digitized nuclear images, indicated that the overall mean values of 16 nuclear 
features discriminated significantly between the complete groups of CIN III and 
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invasive lesions. Based on the results of a stepwise linear discriminant analysis of 
mean values on a patient basis, a combination of two geometrical and two 
runlength texture features was used to discriminate between CIN III and invasive 
lesions. The correct classification rate of the complete groups of CIN III and 
invasive lesions was 78% each. The correct classification rate of CIN III and 
invasive cancer was lowest in the younger age group, being 77% and 60% respec-
tively, and highest in the group of older patients, being 91% and 94% respectively. 
The results of this study indicated that high resolution cytophotometric analysis 
is of value in the discrimination between CIN III and invasive cancer. It was 
suggested that this type of analysis may be of help in the study of progressive and 
non-progressive CIN lesions. 
In chapter 5 the results are described of high resolution cytophotometric analysis 
of 57 cases of CIN III, retrieved from selected areas of paraffin-embedded tissues. 
37 Cases of CIN III of patients without synchronous cervical invasive carcinoma 
were regarded to represent a mixture of progressive and non-progressive lesions. 
20 cases of CIN IH lesions of patients with a synchronous cervical invasive squa-
mous cell carcinoma were regarded to represent truly progressive precursor lesions 
(CIN.INV). Twenty-one photometric features describing geometrical, density and 
texture characteristics were extracted from the digitized nuclear images. Mean (M) 
and standard deviation (S) values of the photometrical features were calculated 
for each specimen. Statistical analysis of the cytophotometric data indicated 
significant differences between the complete groups of true CIN III and CIN Ill-
like lesions concomitant with invasive carcinoma. A cluster analysis, using one co-
occurrency texture feature, one density feature and two geometrical features, 
identified two clusters (CI and C2) in the combined group of CIN III and 
CIN.INV specimens. The vast majority of CIN.INV lesions belonged to cluster 
Cl. The CIN III group appeared to be a mixture of the two clusters, 54 % CI 
and 46 % C2 lesions. The presence of this subgroup of lesions in the group of 
CIN III lesions (cluster Cl) with similar photometric feature values as found in 
the vast majority of CIN.INV lesions, could very well represent a group of potenti-
ally progressive lesions. Based on these findings, in total some 40-50% of CIN III 
lesions would be potentially progressive. In patients older than 45 years, the 
percentage of these potentially progressive CIN III lesions was 27%. In patients 
45 years or younger the percentage of these potentially progressive CIN III lesions 
was 62%. 
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In chapter 6 a cytophotometric analysis was performed of cytological smears 
and corresponding cytospin specimen, retrieved from selected areas of paraffin-
embedded tissues, representing Cervical Intraepithelial Neoplasia grade 3 lesions 
from 22 patients. The average time interval between cytological and histological 
diagnosis was six weeks. A visual classification of DNA ploidy patterns was 
performed, and the 2.5c and 5c exceeding rates were calculated. Furthermore a 
high resolution cytophotometric analysis was performed using the specimen mean 
and standard deviation values of 21 photometric features. A significant correlation 
existed between DNA ploidy patterns in corresponding cytospin specimens made 
from larger epithelial areas and conventional cytological smears. The 2.5c and 5c 
exceeding rates however were found to be significantly higher in the conventional 
cytological smears. Also at high resolution cytophotometric analysis of cell nuclei 
in cytological smears and cytospin specimens made from larger epithelial areas 
specimen, significant differences for a large number of nuclear photometric 
features were found. These findings might result from differences in the selection 
of CIN HI cells from conventional cytological smears and cytospin specimens made 
from larger epithelial areas and by differences in fixation procedures as used for 
the two types of specimens. It is concluded that cytophotometric data of conventi-
onal cytological smears and cytospin specimens made from larger epithelial areas 
representing CIN III lesions should not be regarded as interchangeable among 
each other. 
In chapter 7 DNA ploidy analysis, 2.5C and 5C exceeding rates and high 
resolution cytophotometric analysis were performed in 73 cervical cytological 
smears with cytologial diagnosis of CIN I, II, III and invasive carcinoma from 57 
women, to identify prognostic parameters. From four cervical screening registries 
a group of 28 women was selected on basis of a final histologic diagnosis of 
cervical invasive squamous cell carcinoma, with previous cervical smears consistent 
with CIN I, II and III lesions and who were left untreated. A second group of 
29 patients, who were treated for cytologically diagnosed CIN III was regarded 
to represent a mixture of progressive, persistent and regressive lesions. In 64% 
of cervical smears from the group of patients who had developed invasive cancer, 
a DNA-aneuploid pattern was found both in CIN and in invasive lesions. DNA 
polyploidy was present in 36% of both of these lesions. It was concluded that 
DNA polyploid CIN lesions should not be regarded as possibly reactive or regres-
sive. DNA diploidy did not occur in these CIN or invasive cancer cases. The 2.5C 
exceeding rate increased with increasing severity of the CIN lesion. A high 
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resolution cytophotometric analysis demonstrated a trend-like pattern of a number 
of feature values in lesions with increasing severity, thus from CIN I and CIN II 
to CIN III and invasive cancer. In a cluster analysis based on the results of high 
resolution cytophotometric analysis, a subdivision of CIN III lesions with unknown 
malignant potential was possible into a group of lesions with similar feature values 
as a group of progressive CIN III and a second group of lesions that had feature 
values that were dissimilar to progressive CIN III. It was suggested to apply a 
classifier based on a combination of age, high resolution cytophotometric data and 
ploidy patterns in a prospective study of cytologically detected CIN-lesions. 
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Het natuurlijke beloop van premaligne afwijkingen van de cervix uteri is nog 
niet bekend. Cervicale intra-epitheliale neoplasmata (= CIN of dysplasie en 
carcinoma in situ) kunnen een progressief gedrag vertonen en invasief worden, 
maar kunnen ook persisteren of verdwijnen. Het is niet mogelijk gebleken, op 
basis van cytopathologisch, histopathologisch of kolposkopisch onderzoek, deze 
laesies onder te verdelen in progressieve, persisterende en regressieve sub-types. 
Als gevolg hiervan worden patiënten met CIN laesies behandeld als betrof het 
in alle gevallen, potentieel progressieve laesies. Een techniek die bijdraagt aan 
het onderscheiden van laesies met een progressief karakter en laesies met een 
niet-progressief gedragen, is dringend gewenst. De studie, beschreven in dit proef-
schrift, betreft de toepassing van DNA cytometrische analyse op cervicale intra-
epitheliale neoplasmata, met het doel kenmerken van celkernen te identificeren 
die een afspiegeling vormen van het biologische karakter van de afwijking. 
In hoofdstuk 1 wordt een overzicht gegeven van relevante literatuur over het 
natuurlijk beloop van CIN laesies en over DNA cytogenetisch en cytometrisch 
onderzoek. Daarbij wordt enige extra aandacht geschonken aan de mogelijke 
betekenis van de detectie van humaan papilloma virus (HPV) infectie voor het 
onderscheid tussen progressieve en non-progressieve CIN laesies. 
In hoofdstuk 2 wordt een methode beschreven die ontwikkeld werd om kernen 
te isoleren uit geselecteerde gebieden van in paraffine ingebed weefsel. Daartoe 
worden 50 micrometer dikke coupes gesneden, gedeparaffineerd en gerehydreerd. 
De "dikke" coupes worden op een glaasje gebracht waarna onder een dissectie-
microscoop het geselecteerde gebied kan worden geïsoleerd, door het overtollige 
weefsel met een scalpel te verwijderen. Een optimaal aantal kernen wordt verkre-
gen na incubatie met protease-oplossing. Na wassen kunnen de kernen gebruikt 
worden voor flow-cytometrisch onderzoek. Na suspensie in foetaal calf-serum, 
cytocentrifuge en Thionine-Feulgen kleuring kunnen de kernen geanalyseerd 
worden m.b.v. beeld-analytisch cytometrisch onderzoek. De methode wordt 
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verduidelijkt met voorbeelden van een carcinoma in situ en invasief carcinoom 
van de mamma en een CIN III van de cervix uteri. 
De studie zoals gepresenteerd in hoofdstuk 3 meldt de resultaten van image-
en flow-cytometrische DNA ploidie analyse van kernen, geïsoleerd uit geselecteer-
de CIN III gebieden van in paraffine ingebed weefsel van 20 patiënten met (CIN), 
en 19 patiënten zonder (CIN.INV) synchroon invasief plaveiselcelcarcinoom van 
de cervix. 21 Patiënten waren 35 jaar of jonger en 18 patiënten waren 50 jaar 
of ouder. Een aneuploid DNA-patroon werd ongeveer even frequent gezien in 
de gehele groep van CIN laesies (53%) als in de groep van CIN.INV laesies 
(50%). Verschillen in de verdeling van de DNA ploidie patronen tussen de twee 
leeftijdsgroepen werden waargenomen. Het merendeel van CIN III laesies bij 
vrouwen 50 jaar of ouder was aneuploid, zowel met (70%) als zonder (88%) een 
gelijktijdig aanwezig invasief carcinoom. In de groep jongere vrouwen werd een 
diploid DNA patroon in ongeveer 60% van de CIN.INV laesies getroffen. Bij 
afwezigheid van een invasief carcinoom waren de meeste CIN III laesies poly-
ploid. De DNA patronen van invasieve carcinomen kwamen in het algemeen 
overeen met die van het aangrenzende CIN.INV, suggererend dat de twee laesies 
aan elkaar verwant waren. Deze resultaten wijken nogal af van eerder gepubliceer-
de gegevens over DNA ploidie analyse bij CIN laesies. De prognostische waarde 
van DNA ploidie metingen bij cervicale intra-epitheliale afwijkingen bij vrouwen 
in deze twee leeftijdscategorieën werd daarom nader onderzocht. Parallelle coupes 
van alle preparaten werden immunohistochemisch gekleurd voor humaan papillo-
mavirus kapsel antigeen. Het HPV virus kon aangetoond worden bij vier CIN lae-
sies zonder invasief carcinoom bij de jongere vrouwen. In drie van deze gevallen 
was een DNA-polyploid patroon aanwezig; het vierde geval toonde een bimodaal 
aneuploid DNA-patroon. 
In hoofdstuk 4 werd DNA ploidie analyse en hoge resolutie cytofotometrische 
analyse verricht in een groep van 37 CIN III laesies en 32 gevallen van cervicaal 
invasief plaveiselcelcarcinoom (INV). De patiënten werden onderverdeeld in twee 
leeftijdsgroepen, nl. 45 jaar of jonger en 46 jaar of ouder. De DNA-ploidie 
analyse, verricht op kernen geïsoleerd uit geselecteerde CIN III - en INV gebie-
den van paraffine ingebed materiaal, toonden dat DNA aneuploidie ongeveer even 
frequent was in de totale groep van CIN III laesies (41%) als in de totale groep 
van INV (37%) laesies. Een relatief hoog percentage DNA diploidie werd aange-
troffen in invasieve laesies bij jongere patiënten (73%). DNA Polyploidie was 
relatief frequent (46%) bij CIN III laesies bij jongere vrouwen. Bij oudere 
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vrouwen met CIN III laesies was DNA aneuploidie zeer frequent (82%). Hoge -
resolutie cytofotometrische analyse, van gedigitaliseerde kernen, gaf aan dat de 
gemiddelde waarden van 16 kern-kenmerken een significant onderscheid maakten 
tussen de gehele groep CIN III en INV. Op basis van de resultaten van een 
stapsgewijze lineaire discriminant-analyse van de gemiddelde waarden per patiënte, 
werd de combinatie van twee geometrische en twee textuur-kenmerken gebruikt 
om CIN III en INV laesies te onderscheiden. De groepen van CIN III en INV 
laesies werden juist geclassificeerd in 78%. De juiste classificatie van CIN III en 
INV was het laagst in de jonge leeftijdsgroep, 77% en 60% respectievelijk, en het 
hoogst in de groep van oudere patiënten, 91% en 94% respectievelijk. De 
resultaten van deze studie geven aan dat hoge resolutie cytofotometrische analyse 
van betekenis kan zijn voor het onderscheid tussen CIN III en invasief carcinoom, 
en mogelijk bij de studie van progressieve en niet-progressieve CIN laesies. 
In hoofdstuk 5 wordt een studie beschreven van hoge resolutie cytofotometrische 
analyse van 57 gevallen van CIN III, afkomstig van geselecteerde gebieden van 
in paraffine ingebed weefsel. 37 Gevallen van CIN III van patiënten zonder 
gelijktijdig invasief carcinoom van de cervix, werden beschouwd als een verzame-
ling van progressieve en niet-progressieve laesies. Van 20 gevallen van CIN III 
laesies bij patiënten met een synchroon cervicaal invasief plaveiselcelcarcinoom, 
werd aangenomen dat dit daadwerkelijk progressieve afwijkingen (CIN.INV) waren. 
Per preparaat werden de gemiddelde en standaard deviatie waarden van 21 
fotometrische kenmerken m.b.t. geometrische, dichtheids- en chromatine textuur 
karakteristieken, berekend uit de gedigitaliseerde kernbeelden. Statistische analyse 
van de cytofotometrische gegevens gaf significante verschillen aan tussen de 
complete groepen CIN ΠΙ en CIN.INV. Cluster-analyse, gebruikmakend van een 
chromatine-textuurkenmerk, een dichtheidskenmerk en twee geometrische kenmer­
ken, toonde twee clusters (Cl en C2) aan in de gehele groep van CIN III en 
CIN.INV preparaten. Het overgrote deel van de CIN.INV afwijkingen behoorde 
tot een en dezelfde cluster Cl. De CIN III groep bleek te bestaan uit een 
mengsel van de twee clusters, 54% Cl- en 46% C2-laesies. De aanwezigheid van 
een subgroep in de CIN III groep met overeenkomstige fotometrische waarden 
als de overgrote meerderheid van CIN.INV laesies, zou kunnen duiden op een 
progressieve potentie van deze subgroep. Als deze bevindingen bevestigd worden, 
zou ongeveer 40-50% van de CIN III laesies potentieel progressief zijn. Bij pati­
ënten ouder dan 45 jaar was dit percentage 27%. Bij patiënten 45 jaar en jonger 
was dit percentage 62%. 
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In hoofdstuk 6 wordt een cytofotometrische analyse beschreven van CIN III 
laesies van 22 patiënten met corresponderende cytologische uitstrijkpreparaten 
en cytospin-preparaten, opgewerkt van geselecteerde gebieden van in paraffine 
ingebed weefsel. De gemiddelde interval-periode tussen de cytologische- en 
histologische materiaal-afname was 6 weken. De DNA ploidie patronen en de 
2.5C en 5C exceeding rates werden beoordeeld. Verder werd een hoge resolutie 
cytofotometrische analyse verricht, gebruik makend van de gemiddelde en stan-
daard-deviatie waarde van 21 fotometrische kern kenmerken. Een significante 
correlatie was aanwezig tussen de DNA ploidie patronen in de corresponderende 
paraffinecytospin- en uitstrijk-preparaten. De 2.5c en 5c exceeding rates waren 
echter duidelijk hoger in de uitstrijkpreparaten. De hoge resolutie cytofotometri-
sche analyse van celkernen in uitstrijk- en paraffinecytospin-preparaten toonde 
significante verschillen voor een groot aantal fotometrische kern-kenmerken aan. 
Deze bevindingen kunnen mogelijk verklaard worden door verschillen in selectie 
van CIN III cellen in uitstrijk- en paraffinecytospin-preparaten en door verschillen 
in fixatie-procedures, zoals gebruikt voor de twee technieken. Geconcludeerd wordt 
dat cytofotometrische gegevens van uitstrijk- en paraffinecytospin-preparaten van 
CIN ΠΙ laesies niet zonder meer vergelijkbaar zijn. 
Hoofdstuk 7 maakt melding van de toepassing van DNA ploidie analyse, 2.5C 
en 5C exceeding rate berekeningen en hoge resolutie cytofotometrische analyse 
in 73 uitstrijkpreparaten van 57 vrouwen. Uit vier cervix screening registraties werd 
een groep van 28 vrouwen geselecteerd, die na een eerdere cervix uitstrijk, 
passend bij CIN I, II en III laesies, uiteindelijk een invasief carcinoom hadden 
ontwikkeld. Een tweede groep van 29 patiënten werd geselecteerd die behandeld 
was in verband met de cytologische diagnose CIN III. Van deze groep werd 
verondersteld dat het een menggroep was van progressieve, persisterende en 
regressieve laesies. 
In 64% van de cervix uitstrijken van de patiënten die uiteindelijk kanker hadden 
ontwikkeld, werd een DNA aneuploid patroon gevonden, zowel in de CIN als in 
de invasieve laesies. DNA Polyploidie was aanwezig in 36% van deze laesies. 
Geconcludeerd werd, dat DNA polyploide CIN laesies niet beschouwd kunnen 
worden als mogelijk reactief of regressief. In deze gevallen van progressieve CIN 
laesies en invasieve carcinomen werd geen DNA diploidie aangetroffen. 
Met het toenemen van de ernst van de CIN laesie nam de 2.5C exceeding rate 
toe. De hoge resolutie cytophotometrische analyse gaf aan dat voor een aantal 
parameters een trend te ontdekken was die parallel liep met toenemen van de 
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ernst van de laesie, c.q. van CIN I, CIN II en CIN III naar invasief carcinoom. 
Een cluster analyse, gebaseerd op de resultaten van de hoge resolutie cytophoto-
metrische analyse gaf aan dat de groep van CIN III laesies met een onbekend 
progressief potentieel onder te verdelen was in een groep die overeenkomstige 
kenmerken had als de groep van progressieve CIN III laesies en een tweede 
groep met waarden die niet pasten bij de progressieve CIN III laesies. De huidige 
resultaten rechtvaardigen het starten van een prospectieve studie van CIN laesies 
in cervix uitstrijken. 
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STELLINGEN 
behorende bij het proefschrift 
"DNA cytometry of 
cervical intraepithelial neoplasia" 
A.G.J.M. Hanselaar 
I 
Ten hoogste een op de tien premaligne cervix laesies zal, indien onbehandeld, 
uiteindelijk ontaarden in een invasief plaveiselcelcarcinoom. L.G. Koss, JAMA 261 
5:737-743, 1989. 
II 
DNA-polyploidie is een frekwente bevinding bij progressieve premaligne cervix 
laesies en dient dus niet beschouwd te worden als indicatief voor een regressief 
gedrag. 
III 
Resultaten van DNA-cytometrisch onderzoek van cytologische uitstrijkpreparaten 
en van paraffine-ingebed materiaal zijn niet zonder meer onderling vergelijkbaar. 
IV 
DNA cytometrie kan, mits toegepast onder stringente condities, waardevol blijken 
bij screening van cervix laesies. 
V 
Borderline maligne ovariumtumoren met immunohistochemisch gedetecteerde, 
infiltrerende tumorcellen zijn carcinomen. 
VI 
Kankertherapie maakt een ontwikkeling door waarbij de specificiteit voor tumor 
en patiënt toeneemt. Kanker is als onkruid in een fraaie tuin; het onkruid moet 
gewied worden, de tuin behouden blijven. Adrian Linden, 1985. 
VII 
Huisartsen van patiënten met een maligne proces dienen betrokken te zijn bij 
multidisciplinaire oncologie-besprekingen. Dramatische misinterpretaties van per-
soonlijkheid en thuissituatie van patiënten kunnen zo voorkomen worden. 
Vili 
Patiënt-gebonden wetenschappelijk onderzoek in de pathologie is niet meer 
denkbaar zonder de PALGA. 
IX 
Evaluatie van wetenschappelijk onderzoek dient te geschieden aan de hand van 
publikaties in wetenschappelijke tijdschriften, zeker indien dit (mede-)gefinancierd 
wordt met overheidsgelden. Het is overigens de vraag of de citatie-index hiervoor 
het meest geëigend is. 
X 
Medisch specialisten dienen niet slechts een adviserende, maar een (mede-) 
beslissende stem te hebben in het ziekenhuis management. 
XI 
Sport als ontspanning draagt bij aan een gezond lichaam en een gezonde geest. 
"Top"sport doet dat veelal niet. 
XII 
Baliepersoneel van PTT en NS wedijveren om de hoogste klant-onvriendelijkheid. 
Vooralsnog onbeslist. 
XIII 
Het is absurd dat auto's nog steeds aangedreven worden door een zelfde type 
milieubelastende verbrandingsmotor als 100 jaar geleden. 
Nijmegen, 23 oktober 1990 



